抗生素正確使用原則 張恩本醫師 為恭醫院感染科 2010.03.26. 今日討論的主題 抗生素一般使用原則 抗生素 相關過敏反 應 常見的感染症致病菌

Post on 26-Dec-2015

267 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

Transcript

抗生素正確使用原則

張恩本醫師 為恭醫院感染科

20100326

今日討論的主題

抗生素一般使用原則 抗生素 相關過敏反 應 常見的感染症致病菌 抗生素的分類 抗生素使用常見錯誤 抗素使用的適應症 常見感染症的抗生素療程

抗生素一般使用原則

Narrow spectrum 一種細菌用一種藥物治療 足量藥物治療 完整療程

使用抗生素之前應

用手取得檢體染色培養 用眼觀察染色特徵 用腦社區型感染或院內感染 想想看最可能的致病菌是什麼 藥物敏感性如何

理想的抗生素 Maximal damage to the bacteria minimal damage to the host ndashselective toxicity Single use High effectiveness Low cost No side-effect

Principles of antibiotic therapy Host factors Allergy history Age Body weight Renalliver function Immune status Site of infection pathogen route of

antibiotics Disease severity Pregnancy

Empirical therapy must be adjusted after culture become available

Definite antimicrobial therapy ndashchange broad- spectrum coverage to specific pathogen

De-escalating therapy

Pathogens of community-acquired infection Pulmonary

S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

Pathogens of community-acquired infection

Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

Pathogens of nosocmial infection

Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

Fixed rug eruption

Skin rash (maculopapular)

Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

Antibiotics

Penicillins Beta-lactmase

inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

trimethoprim

Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

sodium

Penicillins

Natural PCNsPenicillin G Penicillin V benzathine

PCN Penicillinase-resistant PCNs

Oxacillin Prostaphylin Amionopenicillins

Amoxicillin Ampicillin Anti-pseudomonal PCNs

Ticarcillin Piperacillin

Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

all other penicillin-susceptible microorganisms

Adverse effects-PCNs

Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

bleeding

Beta-lactambeta-lactamatase inhibitor

Sulbactam Ampicillin + Sulbactam

Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

Tazobactam Piperacillin + Tazobactam

Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

producing Bacteroides species Less active against gram positive

isolates

Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

bleeding

Sulbactam (Maxtam)

Sulbactam is an irreversible inhibitor of beta-lactamase

Combinations of sulbactam with beta-lactam antibiotics

Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

Cephalosporins

First generation Second generation Third generation Fourth generation

Cephalosporins

Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

First Generation

Cefazolin Cefadroxil Ceflexin Cephradine

StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

Second Generation

Cefmetazole Cefuroxime

Cefalor Cefuroxime

above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

Third generation

Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

Cefixime Cefpodoxime ceftibuten

Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

Fourth Generation

Cefepime Cefpirome

Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

Adverse effects of cephalosporins

Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

cephalosporin- allergic patients

Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

CarbapenemGroup Classification

Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

Group 2 Broad-spectrum carbapenems with activity against non-

fermentative Gram-negative bacilli (eg Pseudomonas

Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

Group3 Carbapenems with clinical activity against Methicillin-

Resistant Staphylococcus (eg In development)

J Antimicrob Chemotherapy

Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

especially old patients CRI preexisting seizure disorder or CNS pathology

AminoglycosidesAminoglycosides

Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

- Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

DECREASES the rate of tissue uptake mdash DELAY the onset

of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

will eventually develop toxicity

Fluoroquinolones

Group I

- Nalidixic acid

- Enteric or urinary tract infections Group II

- Ciprofloxacin Ofloxacin Levofloxacin

- GNR (P aeruginosa) S pneumoniae atypicals Group III

- Moxifloxacin Gemifloxacin

- GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

(P aeruginosadarr)

- Respiratory tract infections

GlycopeptidesGlycopeptides

Vancomycin amp Teicoplanin

Non-β-lactam cell wall synthesis inhibitor

Spectrum GPC amp GPB

Avoid oral use except AAC (antibiotic-associated colitis)

Tetracyclines

STD

- Chlamydial

diseases

- Gonorrhea

(doxycycline +

ceftriaxone)

- Syphilis

Rickettsial diseases

Brucellosis

Tularemia

Relapsing fever

Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

group Streptococcus pyogenes

AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

maltophilia

Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

Colistimethate sodium Colistimethate sodium Pseudomonas

aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

colistimethate 6 to 12 mgkg colistimethate sodium per

day 60 kg man recommended dose for

Colomycin is 240 to 480 mg of colistimethate sodium

Nephrotoxicity (damage to the kidneys) and neurotoxicity

抗生素使用常見的五大錯誤

Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

bomb)

Colonization

Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

抗生素使用的適應症

明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

常見感染症之抗生素療程 ( 一 )

感染症療程 ( 天 )

菌血症 敗血症 14

肝膿瘍 21

軟組織感染 7-10

急性腎炎 14

細菌性腦膜炎 10

常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

1048729

肺炎雙球菌肺炎 14 ()

革蘭氏陰性桿菌肺炎1048729

21 ()

退伍軍人協會症1048729

21

奴卡氏菌肺炎1048729

180-360

感染性心內膜炎 28-42

抗生素治療失敗之原因

選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

  • Slide 15
  • Slide 26
  • Slide 27
  • Slide 28

    今日討論的主題

    抗生素一般使用原則 抗生素 相關過敏反 應 常見的感染症致病菌 抗生素的分類 抗生素使用常見錯誤 抗素使用的適應症 常見感染症的抗生素療程

    抗生素一般使用原則

    Narrow spectrum 一種細菌用一種藥物治療 足量藥物治療 完整療程

    使用抗生素之前應

    用手取得檢體染色培養 用眼觀察染色特徵 用腦社區型感染或院內感染 想想看最可能的致病菌是什麼 藥物敏感性如何

    理想的抗生素 Maximal damage to the bacteria minimal damage to the host ndashselective toxicity Single use High effectiveness Low cost No side-effect

    Principles of antibiotic therapy Host factors Allergy history Age Body weight Renalliver function Immune status Site of infection pathogen route of

    antibiotics Disease severity Pregnancy

    Empirical therapy must be adjusted after culture become available

    Definite antimicrobial therapy ndashchange broad- spectrum coverage to specific pathogen

    De-escalating therapy

    Pathogens of community-acquired infection Pulmonary

    S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

    Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

    Pathogens of community-acquired infection

    Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

    Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

    Pathogens of nosocmial infection

    Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

    Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

    Fixed rug eruption

    Skin rash (maculopapular)

    Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

    Antibiotics

    Penicillins Beta-lactmase

    inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

    trimethoprim

    Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

    sodium

    Penicillins

    Natural PCNsPenicillin G Penicillin V benzathine

    PCN Penicillinase-resistant PCNs

    Oxacillin Prostaphylin Amionopenicillins

    Amoxicillin Ampicillin Anti-pseudomonal PCNs

    Ticarcillin Piperacillin

    Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

    Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

    Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

    all other penicillin-susceptible microorganisms

    Adverse effects-PCNs

    Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

    bleeding

    Beta-lactambeta-lactamatase inhibitor

    Sulbactam Ampicillin + Sulbactam

    Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

    Tazobactam Piperacillin + Tazobactam

    Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

    producing Bacteroides species Less active against gram positive

    isolates

    Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

    bleeding

    Sulbactam (Maxtam)

    Sulbactam is an irreversible inhibitor of beta-lactamase

    Combinations of sulbactam with beta-lactam antibiotics

    Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

    gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

    Cephalosporins

    First generation Second generation Third generation Fourth generation

    Cephalosporins

    Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

    First Generation

    Cefazolin Cefadroxil Ceflexin Cephradine

    StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

    Second Generation

    Cefmetazole Cefuroxime

    Cefalor Cefuroxime

    above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

    Third generation

    Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

    Cefixime Cefpodoxime ceftibuten

    Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

    Fourth Generation

    Cefepime Cefpirome

    Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

    Adverse effects of cephalosporins

    Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

    Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

    cephalosporin- allergic patients

    Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

    Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

    bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

    CarbapenemGroup Classification

    Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

    Group 2 Broad-spectrum carbapenems with activity against non-

    fermentative Gram-negative bacilli (eg Pseudomonas

    Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

    Group3 Carbapenems with clinical activity against Methicillin-

    Resistant Staphylococcus (eg In development)

    J Antimicrob Chemotherapy

    Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

    especially old patients CRI preexisting seizure disorder or CNS pathology

    AminoglycosidesAminoglycosides

    Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

    - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

    mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

    Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

    DECREASES the rate of tissue uptake mdash DELAY the onset

    of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

    will eventually develop toxicity

    Fluoroquinolones

    Group I

    - Nalidixic acid

    - Enteric or urinary tract infections Group II

    - Ciprofloxacin Ofloxacin Levofloxacin

    - GNR (P aeruginosa) S pneumoniae atypicals Group III

    - Moxifloxacin Gemifloxacin

    - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

    (P aeruginosadarr)

    - Respiratory tract infections

    GlycopeptidesGlycopeptides

    Vancomycin amp Teicoplanin

    Non-β-lactam cell wall synthesis inhibitor

    Spectrum GPC amp GPB

    Avoid oral use except AAC (antibiotic-associated colitis)

    Tetracyclines

    STD

    - Chlamydial

    diseases

    - Gonorrhea

    (doxycycline +

    ceftriaxone)

    - Syphilis

    Rickettsial diseases

    Brucellosis

    Tularemia

    Relapsing fever

    Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

    MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

    group Streptococcus pyogenes

    AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

    Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

    maltophilia

    Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

    Colistimethate sodium Colistimethate sodium Pseudomonas

    aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

    E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

    colistimethate 6 to 12 mgkg colistimethate sodium per

    day 60 kg man recommended dose for

    Colomycin is 240 to 480 mg of colistimethate sodium

    Nephrotoxicity (damage to the kidneys) and neurotoxicity

    抗生素使用常見的五大錯誤

    Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

    bomb)

    Colonization

    Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

    Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

    抗生素使用的適應症

    明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

    常見感染症之抗生素療程 ( 一 )

    感染症療程 ( 天 )

    菌血症 敗血症 14

    肝膿瘍 21

    軟組織感染 7-10

    急性腎炎 14

    細菌性腦膜炎 10

    常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

    1048729

    肺炎雙球菌肺炎 14 ()

    革蘭氏陰性桿菌肺炎1048729

    21 ()

    退伍軍人協會症1048729

    21

    奴卡氏菌肺炎1048729

    180-360

    感染性心內膜炎 28-42

    抗生素治療失敗之原因

    選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

    • Slide 15
    • Slide 26
    • Slide 27
    • Slide 28

      抗生素一般使用原則

      Narrow spectrum 一種細菌用一種藥物治療 足量藥物治療 完整療程

      使用抗生素之前應

      用手取得檢體染色培養 用眼觀察染色特徵 用腦社區型感染或院內感染 想想看最可能的致病菌是什麼 藥物敏感性如何

      理想的抗生素 Maximal damage to the bacteria minimal damage to the host ndashselective toxicity Single use High effectiveness Low cost No side-effect

      Principles of antibiotic therapy Host factors Allergy history Age Body weight Renalliver function Immune status Site of infection pathogen route of

      antibiotics Disease severity Pregnancy

      Empirical therapy must be adjusted after culture become available

      Definite antimicrobial therapy ndashchange broad- spectrum coverage to specific pathogen

      De-escalating therapy

      Pathogens of community-acquired infection Pulmonary

      S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

      Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

      Pathogens of community-acquired infection

      Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

      Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

      Pathogens of nosocmial infection

      Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

      Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

      Fixed rug eruption

      Skin rash (maculopapular)

      Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

      Antibiotics

      Penicillins Beta-lactmase

      inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

      trimethoprim

      Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

      sodium

      Penicillins

      Natural PCNsPenicillin G Penicillin V benzathine

      PCN Penicillinase-resistant PCNs

      Oxacillin Prostaphylin Amionopenicillins

      Amoxicillin Ampicillin Anti-pseudomonal PCNs

      Ticarcillin Piperacillin

      Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

      Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

      Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

      all other penicillin-susceptible microorganisms

      Adverse effects-PCNs

      Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

      bleeding

      Beta-lactambeta-lactamatase inhibitor

      Sulbactam Ampicillin + Sulbactam

      Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

      Tazobactam Piperacillin + Tazobactam

      Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

      producing Bacteroides species Less active against gram positive

      isolates

      Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

      bleeding

      Sulbactam (Maxtam)

      Sulbactam is an irreversible inhibitor of beta-lactamase

      Combinations of sulbactam with beta-lactam antibiotics

      Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

      gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

      Cephalosporins

      First generation Second generation Third generation Fourth generation

      Cephalosporins

      Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

      First Generation

      Cefazolin Cefadroxil Ceflexin Cephradine

      StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

      Second Generation

      Cefmetazole Cefuroxime

      Cefalor Cefuroxime

      above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

      Third generation

      Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

      Cefixime Cefpodoxime ceftibuten

      Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

      Fourth Generation

      Cefepime Cefpirome

      Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

      Adverse effects of cephalosporins

      Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

      Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

      cephalosporin- allergic patients

      Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

      Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

      bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

      CarbapenemGroup Classification

      Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

      Group 2 Broad-spectrum carbapenems with activity against non-

      fermentative Gram-negative bacilli (eg Pseudomonas

      Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

      Group3 Carbapenems with clinical activity against Methicillin-

      Resistant Staphylococcus (eg In development)

      J Antimicrob Chemotherapy

      Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

      especially old patients CRI preexisting seizure disorder or CNS pathology

      AminoglycosidesAminoglycosides

      Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

      - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

      mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

      Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

      DECREASES the rate of tissue uptake mdash DELAY the onset

      of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

      will eventually develop toxicity

      Fluoroquinolones

      Group I

      - Nalidixic acid

      - Enteric or urinary tract infections Group II

      - Ciprofloxacin Ofloxacin Levofloxacin

      - GNR (P aeruginosa) S pneumoniae atypicals Group III

      - Moxifloxacin Gemifloxacin

      - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

      (P aeruginosadarr)

      - Respiratory tract infections

      GlycopeptidesGlycopeptides

      Vancomycin amp Teicoplanin

      Non-β-lactam cell wall synthesis inhibitor

      Spectrum GPC amp GPB

      Avoid oral use except AAC (antibiotic-associated colitis)

      Tetracyclines

      STD

      - Chlamydial

      diseases

      - Gonorrhea

      (doxycycline +

      ceftriaxone)

      - Syphilis

      Rickettsial diseases

      Brucellosis

      Tularemia

      Relapsing fever

      Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

      MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

      group Streptococcus pyogenes

      AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

      Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

      maltophilia

      Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

      Colistimethate sodium Colistimethate sodium Pseudomonas

      aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

      E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

      colistimethate 6 to 12 mgkg colistimethate sodium per

      day 60 kg man recommended dose for

      Colomycin is 240 to 480 mg of colistimethate sodium

      Nephrotoxicity (damage to the kidneys) and neurotoxicity

      抗生素使用常見的五大錯誤

      Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

      bomb)

      Colonization

      Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

      Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

      抗生素使用的適應症

      明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

      常見感染症之抗生素療程 ( 一 )

      感染症療程 ( 天 )

      菌血症 敗血症 14

      肝膿瘍 21

      軟組織感染 7-10

      急性腎炎 14

      細菌性腦膜炎 10

      常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

      1048729

      肺炎雙球菌肺炎 14 ()

      革蘭氏陰性桿菌肺炎1048729

      21 ()

      退伍軍人協會症1048729

      21

      奴卡氏菌肺炎1048729

      180-360

      感染性心內膜炎 28-42

      抗生素治療失敗之原因

      選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

      • Slide 15
      • Slide 26
      • Slide 27
      • Slide 28

        使用抗生素之前應

        用手取得檢體染色培養 用眼觀察染色特徵 用腦社區型感染或院內感染 想想看最可能的致病菌是什麼 藥物敏感性如何

        理想的抗生素 Maximal damage to the bacteria minimal damage to the host ndashselective toxicity Single use High effectiveness Low cost No side-effect

        Principles of antibiotic therapy Host factors Allergy history Age Body weight Renalliver function Immune status Site of infection pathogen route of

        antibiotics Disease severity Pregnancy

        Empirical therapy must be adjusted after culture become available

        Definite antimicrobial therapy ndashchange broad- spectrum coverage to specific pathogen

        De-escalating therapy

        Pathogens of community-acquired infection Pulmonary

        S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

        Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

        Pathogens of community-acquired infection

        Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

        Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

        Pathogens of nosocmial infection

        Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

        Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

        Fixed rug eruption

        Skin rash (maculopapular)

        Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

        Antibiotics

        Penicillins Beta-lactmase

        inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

        trimethoprim

        Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

        sodium

        Penicillins

        Natural PCNsPenicillin G Penicillin V benzathine

        PCN Penicillinase-resistant PCNs

        Oxacillin Prostaphylin Amionopenicillins

        Amoxicillin Ampicillin Anti-pseudomonal PCNs

        Ticarcillin Piperacillin

        Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

        Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

        Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

        all other penicillin-susceptible microorganisms

        Adverse effects-PCNs

        Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

        bleeding

        Beta-lactambeta-lactamatase inhibitor

        Sulbactam Ampicillin + Sulbactam

        Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

        Tazobactam Piperacillin + Tazobactam

        Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

        producing Bacteroides species Less active against gram positive

        isolates

        Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

        bleeding

        Sulbactam (Maxtam)

        Sulbactam is an irreversible inhibitor of beta-lactamase

        Combinations of sulbactam with beta-lactam antibiotics

        Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

        gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

        Cephalosporins

        First generation Second generation Third generation Fourth generation

        Cephalosporins

        Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

        First Generation

        Cefazolin Cefadroxil Ceflexin Cephradine

        StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

        Second Generation

        Cefmetazole Cefuroxime

        Cefalor Cefuroxime

        above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

        Third generation

        Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

        Cefixime Cefpodoxime ceftibuten

        Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

        Fourth Generation

        Cefepime Cefpirome

        Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

        Adverse effects of cephalosporins

        Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

        Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

        cephalosporin- allergic patients

        Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

        Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

        bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

        CarbapenemGroup Classification

        Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

        Group 2 Broad-spectrum carbapenems with activity against non-

        fermentative Gram-negative bacilli (eg Pseudomonas

        Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

        Group3 Carbapenems with clinical activity against Methicillin-

        Resistant Staphylococcus (eg In development)

        J Antimicrob Chemotherapy

        Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

        especially old patients CRI preexisting seizure disorder or CNS pathology

        AminoglycosidesAminoglycosides

        Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

        - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

        mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

        Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

        DECREASES the rate of tissue uptake mdash DELAY the onset

        of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

        will eventually develop toxicity

        Fluoroquinolones

        Group I

        - Nalidixic acid

        - Enteric or urinary tract infections Group II

        - Ciprofloxacin Ofloxacin Levofloxacin

        - GNR (P aeruginosa) S pneumoniae atypicals Group III

        - Moxifloxacin Gemifloxacin

        - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

        (P aeruginosadarr)

        - Respiratory tract infections

        GlycopeptidesGlycopeptides

        Vancomycin amp Teicoplanin

        Non-β-lactam cell wall synthesis inhibitor

        Spectrum GPC amp GPB

        Avoid oral use except AAC (antibiotic-associated colitis)

        Tetracyclines

        STD

        - Chlamydial

        diseases

        - Gonorrhea

        (doxycycline +

        ceftriaxone)

        - Syphilis

        Rickettsial diseases

        Brucellosis

        Tularemia

        Relapsing fever

        Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

        MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

        group Streptococcus pyogenes

        AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

        Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

        maltophilia

        Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

        Colistimethate sodium Colistimethate sodium Pseudomonas

        aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

        E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

        colistimethate 6 to 12 mgkg colistimethate sodium per

        day 60 kg man recommended dose for

        Colomycin is 240 to 480 mg of colistimethate sodium

        Nephrotoxicity (damage to the kidneys) and neurotoxicity

        抗生素使用常見的五大錯誤

        Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

        bomb)

        Colonization

        Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

        Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

        抗生素使用的適應症

        明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

        常見感染症之抗生素療程 ( 一 )

        感染症療程 ( 天 )

        菌血症 敗血症 14

        肝膿瘍 21

        軟組織感染 7-10

        急性腎炎 14

        細菌性腦膜炎 10

        常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

        1048729

        肺炎雙球菌肺炎 14 ()

        革蘭氏陰性桿菌肺炎1048729

        21 ()

        退伍軍人協會症1048729

        21

        奴卡氏菌肺炎1048729

        180-360

        感染性心內膜炎 28-42

        抗生素治療失敗之原因

        選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

        • Slide 15
        • Slide 26
        • Slide 27
        • Slide 28

          理想的抗生素 Maximal damage to the bacteria minimal damage to the host ndashselective toxicity Single use High effectiveness Low cost No side-effect

          Principles of antibiotic therapy Host factors Allergy history Age Body weight Renalliver function Immune status Site of infection pathogen route of

          antibiotics Disease severity Pregnancy

          Empirical therapy must be adjusted after culture become available

          Definite antimicrobial therapy ndashchange broad- spectrum coverage to specific pathogen

          De-escalating therapy

          Pathogens of community-acquired infection Pulmonary

          S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

          Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

          Pathogens of community-acquired infection

          Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

          Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

          Pathogens of nosocmial infection

          Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

          Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

          Fixed rug eruption

          Skin rash (maculopapular)

          Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

          Antibiotics

          Penicillins Beta-lactmase

          inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

          trimethoprim

          Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

          sodium

          Penicillins

          Natural PCNsPenicillin G Penicillin V benzathine

          PCN Penicillinase-resistant PCNs

          Oxacillin Prostaphylin Amionopenicillins

          Amoxicillin Ampicillin Anti-pseudomonal PCNs

          Ticarcillin Piperacillin

          Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

          Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

          Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

          all other penicillin-susceptible microorganisms

          Adverse effects-PCNs

          Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

          bleeding

          Beta-lactambeta-lactamatase inhibitor

          Sulbactam Ampicillin + Sulbactam

          Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

          Tazobactam Piperacillin + Tazobactam

          Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

          producing Bacteroides species Less active against gram positive

          isolates

          Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

          bleeding

          Sulbactam (Maxtam)

          Sulbactam is an irreversible inhibitor of beta-lactamase

          Combinations of sulbactam with beta-lactam antibiotics

          Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

          gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

          Cephalosporins

          First generation Second generation Third generation Fourth generation

          Cephalosporins

          Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

          First Generation

          Cefazolin Cefadroxil Ceflexin Cephradine

          StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

          Second Generation

          Cefmetazole Cefuroxime

          Cefalor Cefuroxime

          above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

          Third generation

          Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

          Cefixime Cefpodoxime ceftibuten

          Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

          Fourth Generation

          Cefepime Cefpirome

          Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

          Adverse effects of cephalosporins

          Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

          Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

          cephalosporin- allergic patients

          Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

          Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

          bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

          CarbapenemGroup Classification

          Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

          Group 2 Broad-spectrum carbapenems with activity against non-

          fermentative Gram-negative bacilli (eg Pseudomonas

          Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

          Group3 Carbapenems with clinical activity against Methicillin-

          Resistant Staphylococcus (eg In development)

          J Antimicrob Chemotherapy

          Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

          especially old patients CRI preexisting seizure disorder or CNS pathology

          AminoglycosidesAminoglycosides

          Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

          - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

          mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

          Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

          DECREASES the rate of tissue uptake mdash DELAY the onset

          of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

          will eventually develop toxicity

          Fluoroquinolones

          Group I

          - Nalidixic acid

          - Enteric or urinary tract infections Group II

          - Ciprofloxacin Ofloxacin Levofloxacin

          - GNR (P aeruginosa) S pneumoniae atypicals Group III

          - Moxifloxacin Gemifloxacin

          - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

          (P aeruginosadarr)

          - Respiratory tract infections

          GlycopeptidesGlycopeptides

          Vancomycin amp Teicoplanin

          Non-β-lactam cell wall synthesis inhibitor

          Spectrum GPC amp GPB

          Avoid oral use except AAC (antibiotic-associated colitis)

          Tetracyclines

          STD

          - Chlamydial

          diseases

          - Gonorrhea

          (doxycycline +

          ceftriaxone)

          - Syphilis

          Rickettsial diseases

          Brucellosis

          Tularemia

          Relapsing fever

          Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

          MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

          group Streptococcus pyogenes

          AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

          Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

          maltophilia

          Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

          Colistimethate sodium Colistimethate sodium Pseudomonas

          aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

          E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

          colistimethate 6 to 12 mgkg colistimethate sodium per

          day 60 kg man recommended dose for

          Colomycin is 240 to 480 mg of colistimethate sodium

          Nephrotoxicity (damage to the kidneys) and neurotoxicity

          抗生素使用常見的五大錯誤

          Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

          bomb)

          Colonization

          Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

          Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

          抗生素使用的適應症

          明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

          常見感染症之抗生素療程 ( 一 )

          感染症療程 ( 天 )

          菌血症 敗血症 14

          肝膿瘍 21

          軟組織感染 7-10

          急性腎炎 14

          細菌性腦膜炎 10

          常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

          1048729

          肺炎雙球菌肺炎 14 ()

          革蘭氏陰性桿菌肺炎1048729

          21 ()

          退伍軍人協會症1048729

          21

          奴卡氏菌肺炎1048729

          180-360

          感染性心內膜炎 28-42

          抗生素治療失敗之原因

          選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

          • Slide 15
          • Slide 26
          • Slide 27
          • Slide 28

            Principles of antibiotic therapy Host factors Allergy history Age Body weight Renalliver function Immune status Site of infection pathogen route of

            antibiotics Disease severity Pregnancy

            Empirical therapy must be adjusted after culture become available

            Definite antimicrobial therapy ndashchange broad- spectrum coverage to specific pathogen

            De-escalating therapy

            Pathogens of community-acquired infection Pulmonary

            S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

            Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

            Pathogens of community-acquired infection

            Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

            Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

            Pathogens of nosocmial infection

            Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

            Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

            Fixed rug eruption

            Skin rash (maculopapular)

            Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

            Antibiotics

            Penicillins Beta-lactmase

            inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

            trimethoprim

            Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

            sodium

            Penicillins

            Natural PCNsPenicillin G Penicillin V benzathine

            PCN Penicillinase-resistant PCNs

            Oxacillin Prostaphylin Amionopenicillins

            Amoxicillin Ampicillin Anti-pseudomonal PCNs

            Ticarcillin Piperacillin

            Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

            Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

            Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

            all other penicillin-susceptible microorganisms

            Adverse effects-PCNs

            Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

            bleeding

            Beta-lactambeta-lactamatase inhibitor

            Sulbactam Ampicillin + Sulbactam

            Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

            Tazobactam Piperacillin + Tazobactam

            Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

            producing Bacteroides species Less active against gram positive

            isolates

            Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

            bleeding

            Sulbactam (Maxtam)

            Sulbactam is an irreversible inhibitor of beta-lactamase

            Combinations of sulbactam with beta-lactam antibiotics

            Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

            gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

            Cephalosporins

            First generation Second generation Third generation Fourth generation

            Cephalosporins

            Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

            First Generation

            Cefazolin Cefadroxil Ceflexin Cephradine

            StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

            Second Generation

            Cefmetazole Cefuroxime

            Cefalor Cefuroxime

            above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

            Third generation

            Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

            Cefixime Cefpodoxime ceftibuten

            Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

            Fourth Generation

            Cefepime Cefpirome

            Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

            Adverse effects of cephalosporins

            Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

            Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

            cephalosporin- allergic patients

            Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

            Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

            bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

            CarbapenemGroup Classification

            Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

            Group 2 Broad-spectrum carbapenems with activity against non-

            fermentative Gram-negative bacilli (eg Pseudomonas

            Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

            Group3 Carbapenems with clinical activity against Methicillin-

            Resistant Staphylococcus (eg In development)

            J Antimicrob Chemotherapy

            Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

            especially old patients CRI preexisting seizure disorder or CNS pathology

            AminoglycosidesAminoglycosides

            Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

            - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

            mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

            Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

            DECREASES the rate of tissue uptake mdash DELAY the onset

            of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

            will eventually develop toxicity

            Fluoroquinolones

            Group I

            - Nalidixic acid

            - Enteric or urinary tract infections Group II

            - Ciprofloxacin Ofloxacin Levofloxacin

            - GNR (P aeruginosa) S pneumoniae atypicals Group III

            - Moxifloxacin Gemifloxacin

            - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

            (P aeruginosadarr)

            - Respiratory tract infections

            GlycopeptidesGlycopeptides

            Vancomycin amp Teicoplanin

            Non-β-lactam cell wall synthesis inhibitor

            Spectrum GPC amp GPB

            Avoid oral use except AAC (antibiotic-associated colitis)

            Tetracyclines

            STD

            - Chlamydial

            diseases

            - Gonorrhea

            (doxycycline +

            ceftriaxone)

            - Syphilis

            Rickettsial diseases

            Brucellosis

            Tularemia

            Relapsing fever

            Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

            MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

            group Streptococcus pyogenes

            AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

            Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

            maltophilia

            Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

            Colistimethate sodium Colistimethate sodium Pseudomonas

            aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

            E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

            colistimethate 6 to 12 mgkg colistimethate sodium per

            day 60 kg man recommended dose for

            Colomycin is 240 to 480 mg of colistimethate sodium

            Nephrotoxicity (damage to the kidneys) and neurotoxicity

            抗生素使用常見的五大錯誤

            Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

            bomb)

            Colonization

            Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

            Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

            抗生素使用的適應症

            明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

            常見感染症之抗生素療程 ( 一 )

            感染症療程 ( 天 )

            菌血症 敗血症 14

            肝膿瘍 21

            軟組織感染 7-10

            急性腎炎 14

            細菌性腦膜炎 10

            常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

            1048729

            肺炎雙球菌肺炎 14 ()

            革蘭氏陰性桿菌肺炎1048729

            21 ()

            退伍軍人協會症1048729

            21

            奴卡氏菌肺炎1048729

            180-360

            感染性心內膜炎 28-42

            抗生素治療失敗之原因

            選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

            • Slide 15
            • Slide 26
            • Slide 27
            • Slide 28

              Empirical therapy must be adjusted after culture become available

              Definite antimicrobial therapy ndashchange broad- spectrum coverage to specific pathogen

              De-escalating therapy

              Pathogens of community-acquired infection Pulmonary

              S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

              Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

              Pathogens of community-acquired infection

              Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

              Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

              Pathogens of nosocmial infection

              Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

              Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

              Fixed rug eruption

              Skin rash (maculopapular)

              Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

              Antibiotics

              Penicillins Beta-lactmase

              inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

              trimethoprim

              Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

              sodium

              Penicillins

              Natural PCNsPenicillin G Penicillin V benzathine

              PCN Penicillinase-resistant PCNs

              Oxacillin Prostaphylin Amionopenicillins

              Amoxicillin Ampicillin Anti-pseudomonal PCNs

              Ticarcillin Piperacillin

              Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

              Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

              Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

              all other penicillin-susceptible microorganisms

              Adverse effects-PCNs

              Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

              bleeding

              Beta-lactambeta-lactamatase inhibitor

              Sulbactam Ampicillin + Sulbactam

              Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

              Tazobactam Piperacillin + Tazobactam

              Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

              producing Bacteroides species Less active against gram positive

              isolates

              Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

              bleeding

              Sulbactam (Maxtam)

              Sulbactam is an irreversible inhibitor of beta-lactamase

              Combinations of sulbactam with beta-lactam antibiotics

              Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

              gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

              Cephalosporins

              First generation Second generation Third generation Fourth generation

              Cephalosporins

              Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

              First Generation

              Cefazolin Cefadroxil Ceflexin Cephradine

              StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

              Second Generation

              Cefmetazole Cefuroxime

              Cefalor Cefuroxime

              above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

              Third generation

              Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

              Cefixime Cefpodoxime ceftibuten

              Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

              Fourth Generation

              Cefepime Cefpirome

              Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

              Adverse effects of cephalosporins

              Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

              Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

              cephalosporin- allergic patients

              Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

              Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

              bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

              CarbapenemGroup Classification

              Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

              Group 2 Broad-spectrum carbapenems with activity against non-

              fermentative Gram-negative bacilli (eg Pseudomonas

              Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

              Group3 Carbapenems with clinical activity against Methicillin-

              Resistant Staphylococcus (eg In development)

              J Antimicrob Chemotherapy

              Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

              especially old patients CRI preexisting seizure disorder or CNS pathology

              AminoglycosidesAminoglycosides

              Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

              - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

              mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

              Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

              DECREASES the rate of tissue uptake mdash DELAY the onset

              of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

              will eventually develop toxicity

              Fluoroquinolones

              Group I

              - Nalidixic acid

              - Enteric or urinary tract infections Group II

              - Ciprofloxacin Ofloxacin Levofloxacin

              - GNR (P aeruginosa) S pneumoniae atypicals Group III

              - Moxifloxacin Gemifloxacin

              - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

              (P aeruginosadarr)

              - Respiratory tract infections

              GlycopeptidesGlycopeptides

              Vancomycin amp Teicoplanin

              Non-β-lactam cell wall synthesis inhibitor

              Spectrum GPC amp GPB

              Avoid oral use except AAC (antibiotic-associated colitis)

              Tetracyclines

              STD

              - Chlamydial

              diseases

              - Gonorrhea

              (doxycycline +

              ceftriaxone)

              - Syphilis

              Rickettsial diseases

              Brucellosis

              Tularemia

              Relapsing fever

              Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

              MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

              group Streptococcus pyogenes

              AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

              Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

              maltophilia

              Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

              Colistimethate sodium Colistimethate sodium Pseudomonas

              aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

              E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

              colistimethate 6 to 12 mgkg colistimethate sodium per

              day 60 kg man recommended dose for

              Colomycin is 240 to 480 mg of colistimethate sodium

              Nephrotoxicity (damage to the kidneys) and neurotoxicity

              抗生素使用常見的五大錯誤

              Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

              bomb)

              Colonization

              Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

              Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

              抗生素使用的適應症

              明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

              常見感染症之抗生素療程 ( 一 )

              感染症療程 ( 天 )

              菌血症 敗血症 14

              肝膿瘍 21

              軟組織感染 7-10

              急性腎炎 14

              細菌性腦膜炎 10

              常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

              1048729

              肺炎雙球菌肺炎 14 ()

              革蘭氏陰性桿菌肺炎1048729

              21 ()

              退伍軍人協會症1048729

              21

              奴卡氏菌肺炎1048729

              180-360

              感染性心內膜炎 28-42

              抗生素治療失敗之原因

              選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

              • Slide 15
              • Slide 26
              • Slide 27
              • Slide 28

                Pathogens of community-acquired infection Pulmonary

                S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

                Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

                Pathogens of community-acquired infection

                Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

                Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

                Pathogens of nosocmial infection

                Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

                Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

                Fixed rug eruption

                Skin rash (maculopapular)

                Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

                Antibiotics

                Penicillins Beta-lactmase

                inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                trimethoprim

                Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                sodium

                Penicillins

                Natural PCNsPenicillin G Penicillin V benzathine

                PCN Penicillinase-resistant PCNs

                Oxacillin Prostaphylin Amionopenicillins

                Amoxicillin Ampicillin Anti-pseudomonal PCNs

                Ticarcillin Piperacillin

                Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                all other penicillin-susceptible microorganisms

                Adverse effects-PCNs

                Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                bleeding

                Beta-lactambeta-lactamatase inhibitor

                Sulbactam Ampicillin + Sulbactam

                Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                Tazobactam Piperacillin + Tazobactam

                Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                producing Bacteroides species Less active against gram positive

                isolates

                Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                bleeding

                Sulbactam (Maxtam)

                Sulbactam is an irreversible inhibitor of beta-lactamase

                Combinations of sulbactam with beta-lactam antibiotics

                Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                Cephalosporins

                First generation Second generation Third generation Fourth generation

                Cephalosporins

                Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                First Generation

                Cefazolin Cefadroxil Ceflexin Cephradine

                StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                Second Generation

                Cefmetazole Cefuroxime

                Cefalor Cefuroxime

                above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                Third generation

                Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                Cefixime Cefpodoxime ceftibuten

                Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                Fourth Generation

                Cefepime Cefpirome

                Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                Adverse effects of cephalosporins

                Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                cephalosporin- allergic patients

                Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                CarbapenemGroup Classification

                Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                Group 2 Broad-spectrum carbapenems with activity against non-

                fermentative Gram-negative bacilli (eg Pseudomonas

                Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                Group3 Carbapenems with clinical activity against Methicillin-

                Resistant Staphylococcus (eg In development)

                J Antimicrob Chemotherapy

                Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                especially old patients CRI preexisting seizure disorder or CNS pathology

                AminoglycosidesAminoglycosides

                Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                DECREASES the rate of tissue uptake mdash DELAY the onset

                of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                will eventually develop toxicity

                Fluoroquinolones

                Group I

                - Nalidixic acid

                - Enteric or urinary tract infections Group II

                - Ciprofloxacin Ofloxacin Levofloxacin

                - GNR (P aeruginosa) S pneumoniae atypicals Group III

                - Moxifloxacin Gemifloxacin

                - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                (P aeruginosadarr)

                - Respiratory tract infections

                GlycopeptidesGlycopeptides

                Vancomycin amp Teicoplanin

                Non-β-lactam cell wall synthesis inhibitor

                Spectrum GPC amp GPB

                Avoid oral use except AAC (antibiotic-associated colitis)

                Tetracyclines

                STD

                - Chlamydial

                diseases

                - Gonorrhea

                (doxycycline +

                ceftriaxone)

                - Syphilis

                Rickettsial diseases

                Brucellosis

                Tularemia

                Relapsing fever

                Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                group Streptococcus pyogenes

                AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                maltophilia

                Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                Colistimethate sodium Colistimethate sodium Pseudomonas

                aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                colistimethate 6 to 12 mgkg colistimethate sodium per

                day 60 kg man recommended dose for

                Colomycin is 240 to 480 mg of colistimethate sodium

                Nephrotoxicity (damage to the kidneys) and neurotoxicity

                抗生素使用常見的五大錯誤

                Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                bomb)

                Colonization

                Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                抗生素使用的適應症

                明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                常見感染症之抗生素療程 ( 一 )

                感染症療程 ( 天 )

                菌血症 敗血症 14

                肝膿瘍 21

                軟組織感染 7-10

                急性腎炎 14

                細菌性腦膜炎 10

                常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                1048729

                肺炎雙球菌肺炎 14 ()

                革蘭氏陰性桿菌肺炎1048729

                21 ()

                退伍軍人協會症1048729

                21

                奴卡氏菌肺炎1048729

                180-360

                感染性心內膜炎 28-42

                抗生素治療失敗之原因

                選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                • Slide 15
                • Slide 26
                • Slide 27
                • Slide 28

                  Pathogens of community-acquired infection

                  Pulmonary S pneumoniae H influenzae M catarrhalis Skin amp soft tissue Streptococci Staphylococci

                  Enterobacterioceae Intraabdomen Enterobacterioceae Anaerobes Enterococci CNS S pneumoniae H influenzae N meningitidis

                  Pathogens of nosocmial infection

                  Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

                  Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

                  Fixed rug eruption

                  Skin rash (maculopapular)

                  Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

                  Antibiotics

                  Penicillins Beta-lactmase

                  inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                  trimethoprim

                  Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                  sodium

                  Penicillins

                  Natural PCNsPenicillin G Penicillin V benzathine

                  PCN Penicillinase-resistant PCNs

                  Oxacillin Prostaphylin Amionopenicillins

                  Amoxicillin Ampicillin Anti-pseudomonal PCNs

                  Ticarcillin Piperacillin

                  Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                  Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                  Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                  all other penicillin-susceptible microorganisms

                  Adverse effects-PCNs

                  Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                  bleeding

                  Beta-lactambeta-lactamatase inhibitor

                  Sulbactam Ampicillin + Sulbactam

                  Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                  Tazobactam Piperacillin + Tazobactam

                  Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                  producing Bacteroides species Less active against gram positive

                  isolates

                  Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                  bleeding

                  Sulbactam (Maxtam)

                  Sulbactam is an irreversible inhibitor of beta-lactamase

                  Combinations of sulbactam with beta-lactam antibiotics

                  Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                  gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                  Cephalosporins

                  First generation Second generation Third generation Fourth generation

                  Cephalosporins

                  Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                  First Generation

                  Cefazolin Cefadroxil Ceflexin Cephradine

                  StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                  Second Generation

                  Cefmetazole Cefuroxime

                  Cefalor Cefuroxime

                  above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                  Third generation

                  Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                  Cefixime Cefpodoxime ceftibuten

                  Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                  Fourth Generation

                  Cefepime Cefpirome

                  Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                  Adverse effects of cephalosporins

                  Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                  Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                  cephalosporin- allergic patients

                  Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                  Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                  bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                  CarbapenemGroup Classification

                  Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                  Group 2 Broad-spectrum carbapenems with activity against non-

                  fermentative Gram-negative bacilli (eg Pseudomonas

                  Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                  Group3 Carbapenems with clinical activity against Methicillin-

                  Resistant Staphylococcus (eg In development)

                  J Antimicrob Chemotherapy

                  Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                  especially old patients CRI preexisting seizure disorder or CNS pathology

                  AminoglycosidesAminoglycosides

                  Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                  - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                  mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                  Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                  DECREASES the rate of tissue uptake mdash DELAY the onset

                  of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                  will eventually develop toxicity

                  Fluoroquinolones

                  Group I

                  - Nalidixic acid

                  - Enteric or urinary tract infections Group II

                  - Ciprofloxacin Ofloxacin Levofloxacin

                  - GNR (P aeruginosa) S pneumoniae atypicals Group III

                  - Moxifloxacin Gemifloxacin

                  - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                  (P aeruginosadarr)

                  - Respiratory tract infections

                  GlycopeptidesGlycopeptides

                  Vancomycin amp Teicoplanin

                  Non-β-lactam cell wall synthesis inhibitor

                  Spectrum GPC amp GPB

                  Avoid oral use except AAC (antibiotic-associated colitis)

                  Tetracyclines

                  STD

                  - Chlamydial

                  diseases

                  - Gonorrhea

                  (doxycycline +

                  ceftriaxone)

                  - Syphilis

                  Rickettsial diseases

                  Brucellosis

                  Tularemia

                  Relapsing fever

                  Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                  MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                  group Streptococcus pyogenes

                  AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                  Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                  maltophilia

                  Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                  Colistimethate sodium Colistimethate sodium Pseudomonas

                  aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                  E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                  colistimethate 6 to 12 mgkg colistimethate sodium per

                  day 60 kg man recommended dose for

                  Colomycin is 240 to 480 mg of colistimethate sodium

                  Nephrotoxicity (damage to the kidneys) and neurotoxicity

                  抗生素使用常見的五大錯誤

                  Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                  bomb)

                  Colonization

                  Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                  Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                  抗生素使用的適應症

                  明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                  常見感染症之抗生素療程 ( 一 )

                  感染症療程 ( 天 )

                  菌血症 敗血症 14

                  肝膿瘍 21

                  軟組織感染 7-10

                  急性腎炎 14

                  細菌性腦膜炎 10

                  常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                  1048729

                  肺炎雙球菌肺炎 14 ()

                  革蘭氏陰性桿菌肺炎1048729

                  21 ()

                  退伍軍人協會症1048729

                  21

                  奴卡氏菌肺炎1048729

                  180-360

                  感染性心內膜炎 28-42

                  抗生素治療失敗之原因

                  選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                  • Slide 15
                  • Slide 26
                  • Slide 27
                  • Slide 28

                    Pathogens of nosocmial infection

                    Pulmonary Enterobacterioceae Pseudomonas Acinetobacter MRSA Intraabdomen Enterobacterioceae Pseudomonas Anaerobes Enterococci Candida CNS MRSA Pseudomonas

                    Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

                    Fixed rug eruption

                    Skin rash (maculopapular)

                    Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

                    Antibiotics

                    Penicillins Beta-lactmase

                    inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                    trimethoprim

                    Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                    sodium

                    Penicillins

                    Natural PCNsPenicillin G Penicillin V benzathine

                    PCN Penicillinase-resistant PCNs

                    Oxacillin Prostaphylin Amionopenicillins

                    Amoxicillin Ampicillin Anti-pseudomonal PCNs

                    Ticarcillin Piperacillin

                    Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                    Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                    Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                    all other penicillin-susceptible microorganisms

                    Adverse effects-PCNs

                    Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                    bleeding

                    Beta-lactambeta-lactamatase inhibitor

                    Sulbactam Ampicillin + Sulbactam

                    Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                    Tazobactam Piperacillin + Tazobactam

                    Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                    producing Bacteroides species Less active against gram positive

                    isolates

                    Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                    bleeding

                    Sulbactam (Maxtam)

                    Sulbactam is an irreversible inhibitor of beta-lactamase

                    Combinations of sulbactam with beta-lactam antibiotics

                    Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                    gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                    Cephalosporins

                    First generation Second generation Third generation Fourth generation

                    Cephalosporins

                    Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                    First Generation

                    Cefazolin Cefadroxil Ceflexin Cephradine

                    StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                    Second Generation

                    Cefmetazole Cefuroxime

                    Cefalor Cefuroxime

                    above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                    Third generation

                    Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                    Cefixime Cefpodoxime ceftibuten

                    Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                    Fourth Generation

                    Cefepime Cefpirome

                    Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                    Adverse effects of cephalosporins

                    Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                    Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                    cephalosporin- allergic patients

                    Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                    Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                    bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                    CarbapenemGroup Classification

                    Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                    Group 2 Broad-spectrum carbapenems with activity against non-

                    fermentative Gram-negative bacilli (eg Pseudomonas

                    Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                    Group3 Carbapenems with clinical activity against Methicillin-

                    Resistant Staphylococcus (eg In development)

                    J Antimicrob Chemotherapy

                    Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                    especially old patients CRI preexisting seizure disorder or CNS pathology

                    AminoglycosidesAminoglycosides

                    Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                    - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                    mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                    Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                    DECREASES the rate of tissue uptake mdash DELAY the onset

                    of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                    will eventually develop toxicity

                    Fluoroquinolones

                    Group I

                    - Nalidixic acid

                    - Enteric or urinary tract infections Group II

                    - Ciprofloxacin Ofloxacin Levofloxacin

                    - GNR (P aeruginosa) S pneumoniae atypicals Group III

                    - Moxifloxacin Gemifloxacin

                    - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                    (P aeruginosadarr)

                    - Respiratory tract infections

                    GlycopeptidesGlycopeptides

                    Vancomycin amp Teicoplanin

                    Non-β-lactam cell wall synthesis inhibitor

                    Spectrum GPC amp GPB

                    Avoid oral use except AAC (antibiotic-associated colitis)

                    Tetracyclines

                    STD

                    - Chlamydial

                    diseases

                    - Gonorrhea

                    (doxycycline +

                    ceftriaxone)

                    - Syphilis

                    Rickettsial diseases

                    Brucellosis

                    Tularemia

                    Relapsing fever

                    Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                    MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                    group Streptococcus pyogenes

                    AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                    Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                    maltophilia

                    Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                    Colistimethate sodium Colistimethate sodium Pseudomonas

                    aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                    E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                    colistimethate 6 to 12 mgkg colistimethate sodium per

                    day 60 kg man recommended dose for

                    Colomycin is 240 to 480 mg of colistimethate sodium

                    Nephrotoxicity (damage to the kidneys) and neurotoxicity

                    抗生素使用常見的五大錯誤

                    Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                    bomb)

                    Colonization

                    Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                    Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                    抗生素使用的適應症

                    明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                    常見感染症之抗生素療程 ( 一 )

                    感染症療程 ( 天 )

                    菌血症 敗血症 14

                    肝膿瘍 21

                    軟組織感染 7-10

                    急性腎炎 14

                    細菌性腦膜炎 10

                    常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                    1048729

                    肺炎雙球菌肺炎 14 ()

                    革蘭氏陰性桿菌肺炎1048729

                    21 ()

                    退伍軍人協會症1048729

                    21

                    奴卡氏菌肺炎1048729

                    180-360

                    感染性心內膜炎 28-42

                    抗生素治療失敗之原因

                    選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                    • Slide 15
                    • Slide 26
                    • Slide 27
                    • Slide 28

                      Allergic reactions to antibiotics Fixed drug eruption Skin rash (maculopapular) Exfoliativedermatitis Stevens-Johnson Syndrome (Toxic epidermal necrolysis) Anaphylactic shock

                      Fixed rug eruption

                      Skin rash (maculopapular)

                      Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

                      Antibiotics

                      Penicillins Beta-lactmase

                      inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                      trimethoprim

                      Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                      sodium

                      Penicillins

                      Natural PCNsPenicillin G Penicillin V benzathine

                      PCN Penicillinase-resistant PCNs

                      Oxacillin Prostaphylin Amionopenicillins

                      Amoxicillin Ampicillin Anti-pseudomonal PCNs

                      Ticarcillin Piperacillin

                      Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                      Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                      Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                      all other penicillin-susceptible microorganisms

                      Adverse effects-PCNs

                      Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                      bleeding

                      Beta-lactambeta-lactamatase inhibitor

                      Sulbactam Ampicillin + Sulbactam

                      Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                      Tazobactam Piperacillin + Tazobactam

                      Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                      producing Bacteroides species Less active against gram positive

                      isolates

                      Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                      bleeding

                      Sulbactam (Maxtam)

                      Sulbactam is an irreversible inhibitor of beta-lactamase

                      Combinations of sulbactam with beta-lactam antibiotics

                      Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                      gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                      Cephalosporins

                      First generation Second generation Third generation Fourth generation

                      Cephalosporins

                      Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                      First Generation

                      Cefazolin Cefadroxil Ceflexin Cephradine

                      StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                      Second Generation

                      Cefmetazole Cefuroxime

                      Cefalor Cefuroxime

                      above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                      Third generation

                      Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                      Cefixime Cefpodoxime ceftibuten

                      Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                      Fourth Generation

                      Cefepime Cefpirome

                      Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                      Adverse effects of cephalosporins

                      Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                      Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                      cephalosporin- allergic patients

                      Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                      Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                      bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                      CarbapenemGroup Classification

                      Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                      Group 2 Broad-spectrum carbapenems with activity against non-

                      fermentative Gram-negative bacilli (eg Pseudomonas

                      Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                      Group3 Carbapenems with clinical activity against Methicillin-

                      Resistant Staphylococcus (eg In development)

                      J Antimicrob Chemotherapy

                      Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                      especially old patients CRI preexisting seizure disorder or CNS pathology

                      AminoglycosidesAminoglycosides

                      Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                      - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                      mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                      Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                      DECREASES the rate of tissue uptake mdash DELAY the onset

                      of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                      will eventually develop toxicity

                      Fluoroquinolones

                      Group I

                      - Nalidixic acid

                      - Enteric or urinary tract infections Group II

                      - Ciprofloxacin Ofloxacin Levofloxacin

                      - GNR (P aeruginosa) S pneumoniae atypicals Group III

                      - Moxifloxacin Gemifloxacin

                      - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                      (P aeruginosadarr)

                      - Respiratory tract infections

                      GlycopeptidesGlycopeptides

                      Vancomycin amp Teicoplanin

                      Non-β-lactam cell wall synthesis inhibitor

                      Spectrum GPC amp GPB

                      Avoid oral use except AAC (antibiotic-associated colitis)

                      Tetracyclines

                      STD

                      - Chlamydial

                      diseases

                      - Gonorrhea

                      (doxycycline +

                      ceftriaxone)

                      - Syphilis

                      Rickettsial diseases

                      Brucellosis

                      Tularemia

                      Relapsing fever

                      Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                      MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                      group Streptococcus pyogenes

                      AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                      Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                      maltophilia

                      Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                      Colistimethate sodium Colistimethate sodium Pseudomonas

                      aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                      E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                      colistimethate 6 to 12 mgkg colistimethate sodium per

                      day 60 kg man recommended dose for

                      Colomycin is 240 to 480 mg of colistimethate sodium

                      Nephrotoxicity (damage to the kidneys) and neurotoxicity

                      抗生素使用常見的五大錯誤

                      Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                      bomb)

                      Colonization

                      Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                      Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                      抗生素使用的適應症

                      明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                      常見感染症之抗生素療程 ( 一 )

                      感染症療程 ( 天 )

                      菌血症 敗血症 14

                      肝膿瘍 21

                      軟組織感染 7-10

                      急性腎炎 14

                      細菌性腦膜炎 10

                      常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                      1048729

                      肺炎雙球菌肺炎 14 ()

                      革蘭氏陰性桿菌肺炎1048729

                      21 ()

                      退伍軍人協會症1048729

                      21

                      奴卡氏菌肺炎1048729

                      180-360

                      感染性心內膜炎 28-42

                      抗生素治療失敗之原因

                      選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                      • Slide 15
                      • Slide 26
                      • Slide 27
                      • Slide 28

                        Fixed rug eruption

                        Skin rash (maculopapular)

                        Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

                        Antibiotics

                        Penicillins Beta-lactmase

                        inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                        trimethoprim

                        Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                        sodium

                        Penicillins

                        Natural PCNsPenicillin G Penicillin V benzathine

                        PCN Penicillinase-resistant PCNs

                        Oxacillin Prostaphylin Amionopenicillins

                        Amoxicillin Ampicillin Anti-pseudomonal PCNs

                        Ticarcillin Piperacillin

                        Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                        Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                        Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                        all other penicillin-susceptible microorganisms

                        Adverse effects-PCNs

                        Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                        bleeding

                        Beta-lactambeta-lactamatase inhibitor

                        Sulbactam Ampicillin + Sulbactam

                        Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                        Tazobactam Piperacillin + Tazobactam

                        Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                        producing Bacteroides species Less active against gram positive

                        isolates

                        Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                        bleeding

                        Sulbactam (Maxtam)

                        Sulbactam is an irreversible inhibitor of beta-lactamase

                        Combinations of sulbactam with beta-lactam antibiotics

                        Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                        gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                        Cephalosporins

                        First generation Second generation Third generation Fourth generation

                        Cephalosporins

                        Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                        First Generation

                        Cefazolin Cefadroxil Ceflexin Cephradine

                        StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                        Second Generation

                        Cefmetazole Cefuroxime

                        Cefalor Cefuroxime

                        above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                        Third generation

                        Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                        Cefixime Cefpodoxime ceftibuten

                        Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                        Fourth Generation

                        Cefepime Cefpirome

                        Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                        Adverse effects of cephalosporins

                        Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                        Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                        cephalosporin- allergic patients

                        Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                        Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                        bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                        CarbapenemGroup Classification

                        Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                        Group 2 Broad-spectrum carbapenems with activity against non-

                        fermentative Gram-negative bacilli (eg Pseudomonas

                        Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                        Group3 Carbapenems with clinical activity against Methicillin-

                        Resistant Staphylococcus (eg In development)

                        J Antimicrob Chemotherapy

                        Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                        especially old patients CRI preexisting seizure disorder or CNS pathology

                        AminoglycosidesAminoglycosides

                        Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                        - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                        mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                        Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                        DECREASES the rate of tissue uptake mdash DELAY the onset

                        of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                        will eventually develop toxicity

                        Fluoroquinolones

                        Group I

                        - Nalidixic acid

                        - Enteric or urinary tract infections Group II

                        - Ciprofloxacin Ofloxacin Levofloxacin

                        - GNR (P aeruginosa) S pneumoniae atypicals Group III

                        - Moxifloxacin Gemifloxacin

                        - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                        (P aeruginosadarr)

                        - Respiratory tract infections

                        GlycopeptidesGlycopeptides

                        Vancomycin amp Teicoplanin

                        Non-β-lactam cell wall synthesis inhibitor

                        Spectrum GPC amp GPB

                        Avoid oral use except AAC (antibiotic-associated colitis)

                        Tetracyclines

                        STD

                        - Chlamydial

                        diseases

                        - Gonorrhea

                        (doxycycline +

                        ceftriaxone)

                        - Syphilis

                        Rickettsial diseases

                        Brucellosis

                        Tularemia

                        Relapsing fever

                        Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                        MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                        group Streptococcus pyogenes

                        AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                        Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                        maltophilia

                        Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                        Colistimethate sodium Colistimethate sodium Pseudomonas

                        aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                        E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                        colistimethate 6 to 12 mgkg colistimethate sodium per

                        day 60 kg man recommended dose for

                        Colomycin is 240 to 480 mg of colistimethate sodium

                        Nephrotoxicity (damage to the kidneys) and neurotoxicity

                        抗生素使用常見的五大錯誤

                        Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                        bomb)

                        Colonization

                        Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                        Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                        抗生素使用的適應症

                        明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                        常見感染症之抗生素療程 ( 一 )

                        感染症療程 ( 天 )

                        菌血症 敗血症 14

                        肝膿瘍 21

                        軟組織感染 7-10

                        急性腎炎 14

                        細菌性腦膜炎 10

                        常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                        1048729

                        肺炎雙球菌肺炎 14 ()

                        革蘭氏陰性桿菌肺炎1048729

                        21 ()

                        退伍軍人協會症1048729

                        21

                        奴卡氏菌肺炎1048729

                        180-360

                        感染性心內膜炎 28-42

                        抗生素治療失敗之原因

                        選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                        • Slide 15
                        • Slide 26
                        • Slide 27
                        • Slide 28

                          Skin rash (maculopapular)

                          Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

                          Antibiotics

                          Penicillins Beta-lactmase

                          inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                          trimethoprim

                          Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                          sodium

                          Penicillins

                          Natural PCNsPenicillin G Penicillin V benzathine

                          PCN Penicillinase-resistant PCNs

                          Oxacillin Prostaphylin Amionopenicillins

                          Amoxicillin Ampicillin Anti-pseudomonal PCNs

                          Ticarcillin Piperacillin

                          Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                          Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                          Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                          all other penicillin-susceptible microorganisms

                          Adverse effects-PCNs

                          Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                          bleeding

                          Beta-lactambeta-lactamatase inhibitor

                          Sulbactam Ampicillin + Sulbactam

                          Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                          Tazobactam Piperacillin + Tazobactam

                          Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                          producing Bacteroides species Less active against gram positive

                          isolates

                          Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                          bleeding

                          Sulbactam (Maxtam)

                          Sulbactam is an irreversible inhibitor of beta-lactamase

                          Combinations of sulbactam with beta-lactam antibiotics

                          Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                          gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                          Cephalosporins

                          First generation Second generation Third generation Fourth generation

                          Cephalosporins

                          Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                          First Generation

                          Cefazolin Cefadroxil Ceflexin Cephradine

                          StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                          Second Generation

                          Cefmetazole Cefuroxime

                          Cefalor Cefuroxime

                          above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                          Third generation

                          Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                          Cefixime Cefpodoxime ceftibuten

                          Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                          Fourth Generation

                          Cefepime Cefpirome

                          Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                          Adverse effects of cephalosporins

                          Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                          Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                          cephalosporin- allergic patients

                          Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                          Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                          bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                          CarbapenemGroup Classification

                          Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                          Group 2 Broad-spectrum carbapenems with activity against non-

                          fermentative Gram-negative bacilli (eg Pseudomonas

                          Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                          Group3 Carbapenems with clinical activity against Methicillin-

                          Resistant Staphylococcus (eg In development)

                          J Antimicrob Chemotherapy

                          Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                          especially old patients CRI preexisting seizure disorder or CNS pathology

                          AminoglycosidesAminoglycosides

                          Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                          - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                          mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                          Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                          DECREASES the rate of tissue uptake mdash DELAY the onset

                          of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                          will eventually develop toxicity

                          Fluoroquinolones

                          Group I

                          - Nalidixic acid

                          - Enteric or urinary tract infections Group II

                          - Ciprofloxacin Ofloxacin Levofloxacin

                          - GNR (P aeruginosa) S pneumoniae atypicals Group III

                          - Moxifloxacin Gemifloxacin

                          - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                          (P aeruginosadarr)

                          - Respiratory tract infections

                          GlycopeptidesGlycopeptides

                          Vancomycin amp Teicoplanin

                          Non-β-lactam cell wall synthesis inhibitor

                          Spectrum GPC amp GPB

                          Avoid oral use except AAC (antibiotic-associated colitis)

                          Tetracyclines

                          STD

                          - Chlamydial

                          diseases

                          - Gonorrhea

                          (doxycycline +

                          ceftriaxone)

                          - Syphilis

                          Rickettsial diseases

                          Brucellosis

                          Tularemia

                          Relapsing fever

                          Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                          MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                          group Streptococcus pyogenes

                          AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                          Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                          maltophilia

                          Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                          Colistimethate sodium Colistimethate sodium Pseudomonas

                          aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                          E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                          colistimethate 6 to 12 mgkg colistimethate sodium per

                          day 60 kg man recommended dose for

                          Colomycin is 240 to 480 mg of colistimethate sodium

                          Nephrotoxicity (damage to the kidneys) and neurotoxicity

                          抗生素使用常見的五大錯誤

                          Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                          bomb)

                          Colonization

                          Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                          Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                          抗生素使用的適應症

                          明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                          常見感染症之抗生素療程 ( 一 )

                          感染症療程 ( 天 )

                          菌血症 敗血症 14

                          肝膿瘍 21

                          軟組織感染 7-10

                          急性腎炎 14

                          細菌性腦膜炎 10

                          常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                          1048729

                          肺炎雙球菌肺炎 14 ()

                          革蘭氏陰性桿菌肺炎1048729

                          21 ()

                          退伍軍人協會症1048729

                          21

                          奴卡氏菌肺炎1048729

                          180-360

                          感染性心內膜炎 28-42

                          抗生素治療失敗之原因

                          選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                          • Slide 15
                          • Slide 26
                          • Slide 27
                          • Slide 28

                            Stevens-Johnson Syndrome (Toxic epidermal necrolysis)

                            Antibiotics

                            Penicillins Beta-lactmase

                            inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                            trimethoprim

                            Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                            sodium

                            Penicillins

                            Natural PCNsPenicillin G Penicillin V benzathine

                            PCN Penicillinase-resistant PCNs

                            Oxacillin Prostaphylin Amionopenicillins

                            Amoxicillin Ampicillin Anti-pseudomonal PCNs

                            Ticarcillin Piperacillin

                            Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                            Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                            Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                            all other penicillin-susceptible microorganisms

                            Adverse effects-PCNs

                            Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                            bleeding

                            Beta-lactambeta-lactamatase inhibitor

                            Sulbactam Ampicillin + Sulbactam

                            Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                            Tazobactam Piperacillin + Tazobactam

                            Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                            producing Bacteroides species Less active against gram positive

                            isolates

                            Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                            bleeding

                            Sulbactam (Maxtam)

                            Sulbactam is an irreversible inhibitor of beta-lactamase

                            Combinations of sulbactam with beta-lactam antibiotics

                            Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                            gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                            Cephalosporins

                            First generation Second generation Third generation Fourth generation

                            Cephalosporins

                            Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                            First Generation

                            Cefazolin Cefadroxil Ceflexin Cephradine

                            StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                            Second Generation

                            Cefmetazole Cefuroxime

                            Cefalor Cefuroxime

                            above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                            Third generation

                            Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                            Cefixime Cefpodoxime ceftibuten

                            Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                            Fourth Generation

                            Cefepime Cefpirome

                            Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                            Adverse effects of cephalosporins

                            Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                            Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                            cephalosporin- allergic patients

                            Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                            Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                            bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                            CarbapenemGroup Classification

                            Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                            Group 2 Broad-spectrum carbapenems with activity against non-

                            fermentative Gram-negative bacilli (eg Pseudomonas

                            Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                            Group3 Carbapenems with clinical activity against Methicillin-

                            Resistant Staphylococcus (eg In development)

                            J Antimicrob Chemotherapy

                            Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                            especially old patients CRI preexisting seizure disorder or CNS pathology

                            AminoglycosidesAminoglycosides

                            Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                            - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                            mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                            Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                            DECREASES the rate of tissue uptake mdash DELAY the onset

                            of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                            will eventually develop toxicity

                            Fluoroquinolones

                            Group I

                            - Nalidixic acid

                            - Enteric or urinary tract infections Group II

                            - Ciprofloxacin Ofloxacin Levofloxacin

                            - GNR (P aeruginosa) S pneumoniae atypicals Group III

                            - Moxifloxacin Gemifloxacin

                            - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                            (P aeruginosadarr)

                            - Respiratory tract infections

                            GlycopeptidesGlycopeptides

                            Vancomycin amp Teicoplanin

                            Non-β-lactam cell wall synthesis inhibitor

                            Spectrum GPC amp GPB

                            Avoid oral use except AAC (antibiotic-associated colitis)

                            Tetracyclines

                            STD

                            - Chlamydial

                            diseases

                            - Gonorrhea

                            (doxycycline +

                            ceftriaxone)

                            - Syphilis

                            Rickettsial diseases

                            Brucellosis

                            Tularemia

                            Relapsing fever

                            Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                            MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                            group Streptococcus pyogenes

                            AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                            Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                            maltophilia

                            Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                            Colistimethate sodium Colistimethate sodium Pseudomonas

                            aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                            E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                            colistimethate 6 to 12 mgkg colistimethate sodium per

                            day 60 kg man recommended dose for

                            Colomycin is 240 to 480 mg of colistimethate sodium

                            Nephrotoxicity (damage to the kidneys) and neurotoxicity

                            抗生素使用常見的五大錯誤

                            Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                            bomb)

                            Colonization

                            Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                            Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                            抗生素使用的適應症

                            明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                            常見感染症之抗生素療程 ( 一 )

                            感染症療程 ( 天 )

                            菌血症 敗血症 14

                            肝膿瘍 21

                            軟組織感染 7-10

                            急性腎炎 14

                            細菌性腦膜炎 10

                            常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                            1048729

                            肺炎雙球菌肺炎 14 ()

                            革蘭氏陰性桿菌肺炎1048729

                            21 ()

                            退伍軍人協會症1048729

                            21

                            奴卡氏菌肺炎1048729

                            180-360

                            感染性心內膜炎 28-42

                            抗生素治療失敗之原因

                            選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                            • Slide 15
                            • Slide 26
                            • Slide 27
                            • Slide 28

                              Antibiotics

                              Penicillins Beta-lactmase

                              inhibitors Cephalosporins Carbapenems Monobactams Sulfonamides amp

                              trimethoprim

                              Aminoglycosides Quinolones Tetracycline Metronidazole Macrolides Tigecycline Glycopeptide Colistimethate

                              sodium

                              Penicillins

                              Natural PCNsPenicillin G Penicillin V benzathine

                              PCN Penicillinase-resistant PCNs

                              Oxacillin Prostaphylin Amionopenicillins

                              Amoxicillin Ampicillin Anti-pseudomonal PCNs

                              Ticarcillin Piperacillin

                              Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                              Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                              Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                              all other penicillin-susceptible microorganisms

                              Adverse effects-PCNs

                              Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                              bleeding

                              Beta-lactambeta-lactamatase inhibitor

                              Sulbactam Ampicillin + Sulbactam

                              Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                              Tazobactam Piperacillin + Tazobactam

                              Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                              producing Bacteroides species Less active against gram positive

                              isolates

                              Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                              bleeding

                              Sulbactam (Maxtam)

                              Sulbactam is an irreversible inhibitor of beta-lactamase

                              Combinations of sulbactam with beta-lactam antibiotics

                              Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                              gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                              Cephalosporins

                              First generation Second generation Third generation Fourth generation

                              Cephalosporins

                              Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                              First Generation

                              Cefazolin Cefadroxil Ceflexin Cephradine

                              StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                              Second Generation

                              Cefmetazole Cefuroxime

                              Cefalor Cefuroxime

                              above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                              Third generation

                              Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                              Cefixime Cefpodoxime ceftibuten

                              Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                              Fourth Generation

                              Cefepime Cefpirome

                              Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                              Adverse effects of cephalosporins

                              Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                              Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                              cephalosporin- allergic patients

                              Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                              Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                              bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                              CarbapenemGroup Classification

                              Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                              Group 2 Broad-spectrum carbapenems with activity against non-

                              fermentative Gram-negative bacilli (eg Pseudomonas

                              Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                              Group3 Carbapenems with clinical activity against Methicillin-

                              Resistant Staphylococcus (eg In development)

                              J Antimicrob Chemotherapy

                              Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                              especially old patients CRI preexisting seizure disorder or CNS pathology

                              AminoglycosidesAminoglycosides

                              Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                              - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                              mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                              Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                              DECREASES the rate of tissue uptake mdash DELAY the onset

                              of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                              will eventually develop toxicity

                              Fluoroquinolones

                              Group I

                              - Nalidixic acid

                              - Enteric or urinary tract infections Group II

                              - Ciprofloxacin Ofloxacin Levofloxacin

                              - GNR (P aeruginosa) S pneumoniae atypicals Group III

                              - Moxifloxacin Gemifloxacin

                              - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                              (P aeruginosadarr)

                              - Respiratory tract infections

                              GlycopeptidesGlycopeptides

                              Vancomycin amp Teicoplanin

                              Non-β-lactam cell wall synthesis inhibitor

                              Spectrum GPC amp GPB

                              Avoid oral use except AAC (antibiotic-associated colitis)

                              Tetracyclines

                              STD

                              - Chlamydial

                              diseases

                              - Gonorrhea

                              (doxycycline +

                              ceftriaxone)

                              - Syphilis

                              Rickettsial diseases

                              Brucellosis

                              Tularemia

                              Relapsing fever

                              Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                              MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                              group Streptococcus pyogenes

                              AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                              Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                              maltophilia

                              Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                              Colistimethate sodium Colistimethate sodium Pseudomonas

                              aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                              E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                              colistimethate 6 to 12 mgkg colistimethate sodium per

                              day 60 kg man recommended dose for

                              Colomycin is 240 to 480 mg of colistimethate sodium

                              Nephrotoxicity (damage to the kidneys) and neurotoxicity

                              抗生素使用常見的五大錯誤

                              Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                              bomb)

                              Colonization

                              Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                              Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                              抗生素使用的適應症

                              明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                              常見感染症之抗生素療程 ( 一 )

                              感染症療程 ( 天 )

                              菌血症 敗血症 14

                              肝膿瘍 21

                              軟組織感染 7-10

                              急性腎炎 14

                              細菌性腦膜炎 10

                              常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                              1048729

                              肺炎雙球菌肺炎 14 ()

                              革蘭氏陰性桿菌肺炎1048729

                              21 ()

                              退伍軍人協會症1048729

                              21

                              奴卡氏菌肺炎1048729

                              180-360

                              感染性心內膜炎 28-42

                              抗生素治療失敗之原因

                              選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                              • Slide 15
                              • Slide 26
                              • Slide 27
                              • Slide 28

                                Penicillins

                                Natural PCNsPenicillin G Penicillin V benzathine

                                PCN Penicillinase-resistant PCNs

                                Oxacillin Prostaphylin Amionopenicillins

                                Amoxicillin Ampicillin Anti-pseudomonal PCNs

                                Ticarcillin Piperacillin

                                Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                                Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                                Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                                all other penicillin-susceptible microorganisms

                                Adverse effects-PCNs

                                Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                bleeding

                                Beta-lactambeta-lactamatase inhibitor

                                Sulbactam Ampicillin + Sulbactam

                                Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                                Tazobactam Piperacillin + Tazobactam

                                Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                                producing Bacteroides species Less active against gram positive

                                isolates

                                Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                bleeding

                                Sulbactam (Maxtam)

                                Sulbactam is an irreversible inhibitor of beta-lactamase

                                Combinations of sulbactam with beta-lactam antibiotics

                                Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                Cephalosporins

                                First generation Second generation Third generation Fourth generation

                                Cephalosporins

                                Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                First Generation

                                Cefazolin Cefadroxil Ceflexin Cephradine

                                StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                Second Generation

                                Cefmetazole Cefuroxime

                                Cefalor Cefuroxime

                                above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                Third generation

                                Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                Cefixime Cefpodoxime ceftibuten

                                Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                Fourth Generation

                                Cefepime Cefpirome

                                Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                Adverse effects of cephalosporins

                                Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                cephalosporin- allergic patients

                                Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                CarbapenemGroup Classification

                                Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                Group 2 Broad-spectrum carbapenems with activity against non-

                                fermentative Gram-negative bacilli (eg Pseudomonas

                                Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                Group3 Carbapenems with clinical activity against Methicillin-

                                Resistant Staphylococcus (eg In development)

                                J Antimicrob Chemotherapy

                                Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                especially old patients CRI preexisting seizure disorder or CNS pathology

                                AminoglycosidesAminoglycosides

                                Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                DECREASES the rate of tissue uptake mdash DELAY the onset

                                of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                will eventually develop toxicity

                                Fluoroquinolones

                                Group I

                                - Nalidixic acid

                                - Enteric or urinary tract infections Group II

                                - Ciprofloxacin Ofloxacin Levofloxacin

                                - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                - Moxifloxacin Gemifloxacin

                                - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                (P aeruginosadarr)

                                - Respiratory tract infections

                                GlycopeptidesGlycopeptides

                                Vancomycin amp Teicoplanin

                                Non-β-lactam cell wall synthesis inhibitor

                                Spectrum GPC amp GPB

                                Avoid oral use except AAC (antibiotic-associated colitis)

                                Tetracyclines

                                STD

                                - Chlamydial

                                diseases

                                - Gonorrhea

                                (doxycycline +

                                ceftriaxone)

                                - Syphilis

                                Rickettsial diseases

                                Brucellosis

                                Tularemia

                                Relapsing fever

                                Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                group Streptococcus pyogenes

                                AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                maltophilia

                                Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                Colistimethate sodium Colistimethate sodium Pseudomonas

                                aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                colistimethate 6 to 12 mgkg colistimethate sodium per

                                day 60 kg man recommended dose for

                                Colomycin is 240 to 480 mg of colistimethate sodium

                                Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                抗生素使用常見的五大錯誤

                                Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                bomb)

                                Colonization

                                Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                抗生素使用的適應症

                                明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                常見感染症之抗生素療程 ( 一 )

                                感染症療程 ( 天 )

                                菌血症 敗血症 14

                                肝膿瘍 21

                                軟組織感染 7-10

                                急性腎炎 14

                                細菌性腦膜炎 10

                                常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                1048729

                                肺炎雙球菌肺炎 14 ()

                                革蘭氏陰性桿菌肺炎1048729

                                21 ()

                                退伍軍人協會症1048729

                                21

                                奴卡氏菌肺炎1048729

                                180-360

                                感染性心內膜炎 28-42

                                抗生素治療失敗之原因

                                選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                • Slide 15
                                • Slide 26
                                • Slide 27
                                • Slide 28

                                  Antimicrobial spectrum of Penicillin-G Streptococcus spp Anaerobes Neisseria spp (Meningococcus

                                  Gonococcus) Actinomycosis Animal bite (Pasteurella multocida) 螺旋體 Syphilis Leptospirosis

                                  Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                                  all other penicillin-susceptible microorganisms

                                  Adverse effects-PCNs

                                  Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                  bleeding

                                  Beta-lactambeta-lactamatase inhibitor

                                  Sulbactam Ampicillin + Sulbactam

                                  Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                                  Tazobactam Piperacillin + Tazobactam

                                  Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                                  producing Bacteroides species Less active against gram positive

                                  isolates

                                  Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                  bleeding

                                  Sulbactam (Maxtam)

                                  Sulbactam is an irreversible inhibitor of beta-lactamase

                                  Combinations of sulbactam with beta-lactam antibiotics

                                  Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                  gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                  Cephalosporins

                                  First generation Second generation Third generation Fourth generation

                                  Cephalosporins

                                  Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                  First Generation

                                  Cefazolin Cefadroxil Ceflexin Cephradine

                                  StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                  Second Generation

                                  Cefmetazole Cefuroxime

                                  Cefalor Cefuroxime

                                  above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                  Third generation

                                  Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                  Cefixime Cefpodoxime ceftibuten

                                  Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                  Fourth Generation

                                  Cefepime Cefpirome

                                  Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                  Adverse effects of cephalosporins

                                  Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                  Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                  cephalosporin- allergic patients

                                  Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                  Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                  bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                  CarbapenemGroup Classification

                                  Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                  Group 2 Broad-spectrum carbapenems with activity against non-

                                  fermentative Gram-negative bacilli (eg Pseudomonas

                                  Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                  Group3 Carbapenems with clinical activity against Methicillin-

                                  Resistant Staphylococcus (eg In development)

                                  J Antimicrob Chemotherapy

                                  Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                  especially old patients CRI preexisting seizure disorder or CNS pathology

                                  AminoglycosidesAminoglycosides

                                  Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                  - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                  mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                  Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                  DECREASES the rate of tissue uptake mdash DELAY the onset

                                  of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                  will eventually develop toxicity

                                  Fluoroquinolones

                                  Group I

                                  - Nalidixic acid

                                  - Enteric or urinary tract infections Group II

                                  - Ciprofloxacin Ofloxacin Levofloxacin

                                  - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                  - Moxifloxacin Gemifloxacin

                                  - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                  (P aeruginosadarr)

                                  - Respiratory tract infections

                                  GlycopeptidesGlycopeptides

                                  Vancomycin amp Teicoplanin

                                  Non-β-lactam cell wall synthesis inhibitor

                                  Spectrum GPC amp GPB

                                  Avoid oral use except AAC (antibiotic-associated colitis)

                                  Tetracyclines

                                  STD

                                  - Chlamydial

                                  diseases

                                  - Gonorrhea

                                  (doxycycline +

                                  ceftriaxone)

                                  - Syphilis

                                  Rickettsial diseases

                                  Brucellosis

                                  Tularemia

                                  Relapsing fever

                                  Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                  MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                  group Streptococcus pyogenes

                                  AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                  Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                  maltophilia

                                  Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                  Colistimethate sodium Colistimethate sodium Pseudomonas

                                  aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                  E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                  colistimethate 6 to 12 mgkg colistimethate sodium per

                                  day 60 kg man recommended dose for

                                  Colomycin is 240 to 480 mg of colistimethate sodium

                                  Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                  抗生素使用常見的五大錯誤

                                  Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                  bomb)

                                  Colonization

                                  Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                  Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                  抗生素使用的適應症

                                  明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                  常見感染症之抗生素療程 ( 一 )

                                  感染症療程 ( 天 )

                                  菌血症 敗血症 14

                                  肝膿瘍 21

                                  軟組織感染 7-10

                                  急性腎炎 14

                                  細菌性腦膜炎 10

                                  常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                  1048729

                                  肺炎雙球菌肺炎 14 ()

                                  革蘭氏陰性桿菌肺炎1048729

                                  21 ()

                                  退伍軍人協會症1048729

                                  21

                                  奴卡氏菌肺炎1048729

                                  180-360

                                  感染性心內膜炎 28-42

                                  抗生素治療失敗之原因

                                  選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                  • Slide 15
                                  • Slide 26
                                  • Slide 27
                                  • Slide 28

                                    Penicillinase-resistant Penicillins oxacillin Penicillinase (β-lactamase) inhibitor Anti-staphylococcal penicillins Less active than penicillin-G against

                                    all other penicillin-susceptible microorganisms

                                    Adverse effects-PCNs

                                    Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                    bleeding

                                    Beta-lactambeta-lactamatase inhibitor

                                    Sulbactam Ampicillin + Sulbactam

                                    Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                                    Tazobactam Piperacillin + Tazobactam

                                    Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                                    producing Bacteroides species Less active against gram positive

                                    isolates

                                    Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                    bleeding

                                    Sulbactam (Maxtam)

                                    Sulbactam is an irreversible inhibitor of beta-lactamase

                                    Combinations of sulbactam with beta-lactam antibiotics

                                    Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                    gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                    Cephalosporins

                                    First generation Second generation Third generation Fourth generation

                                    Cephalosporins

                                    Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                    First Generation

                                    Cefazolin Cefadroxil Ceflexin Cephradine

                                    StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                    Second Generation

                                    Cefmetazole Cefuroxime

                                    Cefalor Cefuroxime

                                    above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                    Third generation

                                    Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                    Cefixime Cefpodoxime ceftibuten

                                    Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                    Fourth Generation

                                    Cefepime Cefpirome

                                    Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                    Adverse effects of cephalosporins

                                    Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                    Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                    cephalosporin- allergic patients

                                    Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                    Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                    bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                    CarbapenemGroup Classification

                                    Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                    Group 2 Broad-spectrum carbapenems with activity against non-

                                    fermentative Gram-negative bacilli (eg Pseudomonas

                                    Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                    Group3 Carbapenems with clinical activity against Methicillin-

                                    Resistant Staphylococcus (eg In development)

                                    J Antimicrob Chemotherapy

                                    Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                    especially old patients CRI preexisting seizure disorder or CNS pathology

                                    AminoglycosidesAminoglycosides

                                    Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                    - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                    mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                    Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                    DECREASES the rate of tissue uptake mdash DELAY the onset

                                    of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                    will eventually develop toxicity

                                    Fluoroquinolones

                                    Group I

                                    - Nalidixic acid

                                    - Enteric or urinary tract infections Group II

                                    - Ciprofloxacin Ofloxacin Levofloxacin

                                    - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                    - Moxifloxacin Gemifloxacin

                                    - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                    (P aeruginosadarr)

                                    - Respiratory tract infections

                                    GlycopeptidesGlycopeptides

                                    Vancomycin amp Teicoplanin

                                    Non-β-lactam cell wall synthesis inhibitor

                                    Spectrum GPC amp GPB

                                    Avoid oral use except AAC (antibiotic-associated colitis)

                                    Tetracyclines

                                    STD

                                    - Chlamydial

                                    diseases

                                    - Gonorrhea

                                    (doxycycline +

                                    ceftriaxone)

                                    - Syphilis

                                    Rickettsial diseases

                                    Brucellosis

                                    Tularemia

                                    Relapsing fever

                                    Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                    MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                    group Streptococcus pyogenes

                                    AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                    Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                    maltophilia

                                    Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                    Colistimethate sodium Colistimethate sodium Pseudomonas

                                    aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                    E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                    colistimethate 6 to 12 mgkg colistimethate sodium per

                                    day 60 kg man recommended dose for

                                    Colomycin is 240 to 480 mg of colistimethate sodium

                                    Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                    抗生素使用常見的五大錯誤

                                    Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                    bomb)

                                    Colonization

                                    Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                    Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                    抗生素使用的適應症

                                    明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                    常見感染症之抗生素療程 ( 一 )

                                    感染症療程 ( 天 )

                                    菌血症 敗血症 14

                                    肝膿瘍 21

                                    軟組織感染 7-10

                                    急性腎炎 14

                                    細菌性腦膜炎 10

                                    常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                    1048729

                                    肺炎雙球菌肺炎 14 ()

                                    革蘭氏陰性桿菌肺炎1048729

                                    21 ()

                                    退伍軍人協會症1048729

                                    21

                                    奴卡氏菌肺炎1048729

                                    180-360

                                    感染性心內膜炎 28-42

                                    抗生素治療失敗之原因

                                    選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                    • Slide 15
                                    • Slide 26
                                    • Slide 27
                                    • Slide 28

                                      Adverse effects-PCNs

                                      Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                      bleeding

                                      Beta-lactambeta-lactamatase inhibitor

                                      Sulbactam Ampicillin + Sulbactam

                                      Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                                      Tazobactam Piperacillin + Tazobactam

                                      Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                                      producing Bacteroides species Less active against gram positive

                                      isolates

                                      Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                      bleeding

                                      Sulbactam (Maxtam)

                                      Sulbactam is an irreversible inhibitor of beta-lactamase

                                      Combinations of sulbactam with beta-lactam antibiotics

                                      Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                      gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                      Cephalosporins

                                      First generation Second generation Third generation Fourth generation

                                      Cephalosporins

                                      Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                      First Generation

                                      Cefazolin Cefadroxil Ceflexin Cephradine

                                      StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                      Second Generation

                                      Cefmetazole Cefuroxime

                                      Cefalor Cefuroxime

                                      above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                      Third generation

                                      Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                      Cefixime Cefpodoxime ceftibuten

                                      Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                      Fourth Generation

                                      Cefepime Cefpirome

                                      Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                      Adverse effects of cephalosporins

                                      Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                      Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                      cephalosporin- allergic patients

                                      Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                      Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                      bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                      CarbapenemGroup Classification

                                      Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                      Group 2 Broad-spectrum carbapenems with activity against non-

                                      fermentative Gram-negative bacilli (eg Pseudomonas

                                      Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                      Group3 Carbapenems with clinical activity against Methicillin-

                                      Resistant Staphylococcus (eg In development)

                                      J Antimicrob Chemotherapy

                                      Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                      especially old patients CRI preexisting seizure disorder or CNS pathology

                                      AminoglycosidesAminoglycosides

                                      Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                      - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                      mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                      Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                      DECREASES the rate of tissue uptake mdash DELAY the onset

                                      of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                      will eventually develop toxicity

                                      Fluoroquinolones

                                      Group I

                                      - Nalidixic acid

                                      - Enteric or urinary tract infections Group II

                                      - Ciprofloxacin Ofloxacin Levofloxacin

                                      - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                      - Moxifloxacin Gemifloxacin

                                      - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                      (P aeruginosadarr)

                                      - Respiratory tract infections

                                      GlycopeptidesGlycopeptides

                                      Vancomycin amp Teicoplanin

                                      Non-β-lactam cell wall synthesis inhibitor

                                      Spectrum GPC amp GPB

                                      Avoid oral use except AAC (antibiotic-associated colitis)

                                      Tetracyclines

                                      STD

                                      - Chlamydial

                                      diseases

                                      - Gonorrhea

                                      (doxycycline +

                                      ceftriaxone)

                                      - Syphilis

                                      Rickettsial diseases

                                      Brucellosis

                                      Tularemia

                                      Relapsing fever

                                      Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                      MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                      group Streptococcus pyogenes

                                      AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                      Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                      maltophilia

                                      Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                      Colistimethate sodium Colistimethate sodium Pseudomonas

                                      aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                      E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                      colistimethate 6 to 12 mgkg colistimethate sodium per

                                      day 60 kg man recommended dose for

                                      Colomycin is 240 to 480 mg of colistimethate sodium

                                      Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                      抗生素使用常見的五大錯誤

                                      Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                      bomb)

                                      Colonization

                                      Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                      Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                      抗生素使用的適應症

                                      明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                      常見感染症之抗生素療程 ( 一 )

                                      感染症療程 ( 天 )

                                      菌血症 敗血症 14

                                      肝膿瘍 21

                                      軟組織感染 7-10

                                      急性腎炎 14

                                      細菌性腦膜炎 10

                                      常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                      1048729

                                      肺炎雙球菌肺炎 14 ()

                                      革蘭氏陰性桿菌肺炎1048729

                                      21 ()

                                      退伍軍人協會症1048729

                                      21

                                      奴卡氏菌肺炎1048729

                                      180-360

                                      感染性心內膜炎 28-42

                                      抗生素治療失敗之原因

                                      選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                      • Slide 15
                                      • Slide 26
                                      • Slide 27
                                      • Slide 28

                                        Beta-lactambeta-lactamatase inhibitor

                                        Sulbactam Ampicillin + Sulbactam

                                        Clavulanic acid Amoxycillin + ClavulanateTicarcillin + Clavulanate

                                        Tazobactam Piperacillin + Tazobactam

                                        Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                                        producing Bacteroides species Less active against gram positive

                                        isolates

                                        Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                        bleeding

                                        Sulbactam (Maxtam)

                                        Sulbactam is an irreversible inhibitor of beta-lactamase

                                        Combinations of sulbactam with beta-lactam antibiotics

                                        Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                        gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                        Cephalosporins

                                        First generation Second generation Third generation Fourth generation

                                        Cephalosporins

                                        Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                        First Generation

                                        Cefazolin Cefadroxil Ceflexin Cephradine

                                        StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                        Second Generation

                                        Cefmetazole Cefuroxime

                                        Cefalor Cefuroxime

                                        above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                        Third generation

                                        Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                        Cefixime Cefpodoxime ceftibuten

                                        Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                        Fourth Generation

                                        Cefepime Cefpirome

                                        Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                        Adverse effects of cephalosporins

                                        Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                        Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                        cephalosporin- allergic patients

                                        Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                        Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                        bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                        CarbapenemGroup Classification

                                        Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                        Group 2 Broad-spectrum carbapenems with activity against non-

                                        fermentative Gram-negative bacilli (eg Pseudomonas

                                        Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                        Group3 Carbapenems with clinical activity against Methicillin-

                                        Resistant Staphylococcus (eg In development)

                                        J Antimicrob Chemotherapy

                                        Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                        especially old patients CRI preexisting seizure disorder or CNS pathology

                                        AminoglycosidesAminoglycosides

                                        Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                        - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                        mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                        Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                        DECREASES the rate of tissue uptake mdash DELAY the onset

                                        of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                        will eventually develop toxicity

                                        Fluoroquinolones

                                        Group I

                                        - Nalidixic acid

                                        - Enteric or urinary tract infections Group II

                                        - Ciprofloxacin Ofloxacin Levofloxacin

                                        - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                        - Moxifloxacin Gemifloxacin

                                        - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                        (P aeruginosadarr)

                                        - Respiratory tract infections

                                        GlycopeptidesGlycopeptides

                                        Vancomycin amp Teicoplanin

                                        Non-β-lactam cell wall synthesis inhibitor

                                        Spectrum GPC amp GPB

                                        Avoid oral use except AAC (antibiotic-associated colitis)

                                        Tetracyclines

                                        STD

                                        - Chlamydial

                                        diseases

                                        - Gonorrhea

                                        (doxycycline +

                                        ceftriaxone)

                                        - Syphilis

                                        Rickettsial diseases

                                        Brucellosis

                                        Tularemia

                                        Relapsing fever

                                        Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                        MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                        group Streptococcus pyogenes

                                        AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                        Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                        maltophilia

                                        Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                        Colistimethate sodium Colistimethate sodium Pseudomonas

                                        aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                        E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                        colistimethate 6 to 12 mgkg colistimethate sodium per

                                        day 60 kg man recommended dose for

                                        Colomycin is 240 to 480 mg of colistimethate sodium

                                        Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                        抗生素使用常見的五大錯誤

                                        Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                        bomb)

                                        Colonization

                                        Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                        Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                        抗生素使用的適應症

                                        明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                        常見感染症之抗生素療程 ( 一 )

                                        感染症療程 ( 天 )

                                        菌血症 敗血症 14

                                        肝膿瘍 21

                                        軟組織感染 7-10

                                        急性腎炎 14

                                        細菌性腦膜炎 10

                                        常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                        1048729

                                        肺炎雙球菌肺炎 14 ()

                                        革蘭氏陰性桿菌肺炎1048729

                                        21 ()

                                        退伍軍人協會症1048729

                                        21

                                        奴卡氏菌肺炎1048729

                                        180-360

                                        感染性心內膜炎 28-42

                                        抗生素治療失敗之原因

                                        選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                        • Slide 15
                                        • Slide 26
                                        • Slide 27
                                        • Slide 28

                                          Antipseudomonal Penicillins Piptazo Ticarcillin + Clavulanate Pseudomonas species Many strains of Enterobacter Anaerobics except β-lactamase

                                          producing Bacteroides species Less active against gram positive

                                          isolates

                                          Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                          bleeding

                                          Sulbactam (Maxtam)

                                          Sulbactam is an irreversible inhibitor of beta-lactamase

                                          Combinations of sulbactam with beta-lactam antibiotics

                                          Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                          gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                          Cephalosporins

                                          First generation Second generation Third generation Fourth generation

                                          Cephalosporins

                                          Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                          First Generation

                                          Cefazolin Cefadroxil Ceflexin Cephradine

                                          StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                          Second Generation

                                          Cefmetazole Cefuroxime

                                          Cefalor Cefuroxime

                                          above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                          Third generation

                                          Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                          Cefixime Cefpodoxime ceftibuten

                                          Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                          Fourth Generation

                                          Cefepime Cefpirome

                                          Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                          Adverse effects of cephalosporins

                                          Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                          Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                          cephalosporin- allergic patients

                                          Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                          Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                          bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                          CarbapenemGroup Classification

                                          Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                          Group 2 Broad-spectrum carbapenems with activity against non-

                                          fermentative Gram-negative bacilli (eg Pseudomonas

                                          Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                          Group3 Carbapenems with clinical activity against Methicillin-

                                          Resistant Staphylococcus (eg In development)

                                          J Antimicrob Chemotherapy

                                          Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                          especially old patients CRI preexisting seizure disorder or CNS pathology

                                          AminoglycosidesAminoglycosides

                                          Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                          - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                          mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                          Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                          DECREASES the rate of tissue uptake mdash DELAY the onset

                                          of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                          will eventually develop toxicity

                                          Fluoroquinolones

                                          Group I

                                          - Nalidixic acid

                                          - Enteric or urinary tract infections Group II

                                          - Ciprofloxacin Ofloxacin Levofloxacin

                                          - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                          - Moxifloxacin Gemifloxacin

                                          - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                          (P aeruginosadarr)

                                          - Respiratory tract infections

                                          GlycopeptidesGlycopeptides

                                          Vancomycin amp Teicoplanin

                                          Non-β-lactam cell wall synthesis inhibitor

                                          Spectrum GPC amp GPB

                                          Avoid oral use except AAC (antibiotic-associated colitis)

                                          Tetracyclines

                                          STD

                                          - Chlamydial

                                          diseases

                                          - Gonorrhea

                                          (doxycycline +

                                          ceftriaxone)

                                          - Syphilis

                                          Rickettsial diseases

                                          Brucellosis

                                          Tularemia

                                          Relapsing fever

                                          Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                          MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                          group Streptococcus pyogenes

                                          AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                          Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                          maltophilia

                                          Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                          Colistimethate sodium Colistimethate sodium Pseudomonas

                                          aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                          E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                          colistimethate 6 to 12 mgkg colistimethate sodium per

                                          day 60 kg man recommended dose for

                                          Colomycin is 240 to 480 mg of colistimethate sodium

                                          Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                          抗生素使用常見的五大錯誤

                                          Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                          bomb)

                                          Colonization

                                          Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                          Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                          抗生素使用的適應症

                                          明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                          常見感染症之抗生素療程 ( 一 )

                                          感染症療程 ( 天 )

                                          菌血症 敗血症 14

                                          肝膿瘍 21

                                          軟組織感染 7-10

                                          急性腎炎 14

                                          細菌性腦膜炎 10

                                          常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                          1048729

                                          肺炎雙球菌肺炎 14 ()

                                          革蘭氏陰性桿菌肺炎1048729

                                          21 ()

                                          退伍軍人協會症1048729

                                          21

                                          奴卡氏菌肺炎1048729

                                          180-360

                                          感染性心內膜炎 28-42

                                          抗生素治療失敗之原因

                                          選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                          • Slide 15
                                          • Slide 26
                                          • Slide 27
                                          • Slide 28

                                            Adverse effects of penicillin Anaphylaxis anemia leukopenia Oxacillin hepatitis Ticarcillin coagulation abnormality

                                            bleeding

                                            Sulbactam (Maxtam)

                                            Sulbactam is an irreversible inhibitor of beta-lactamase

                                            Combinations of sulbactam with beta-lactam antibiotics

                                            Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                            gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                            Cephalosporins

                                            First generation Second generation Third generation Fourth generation

                                            Cephalosporins

                                            Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                            First Generation

                                            Cefazolin Cefadroxil Ceflexin Cephradine

                                            StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                            Second Generation

                                            Cefmetazole Cefuroxime

                                            Cefalor Cefuroxime

                                            above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                            Third generation

                                            Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                            Cefixime Cefpodoxime ceftibuten

                                            Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                            Fourth Generation

                                            Cefepime Cefpirome

                                            Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                            Adverse effects of cephalosporins

                                            Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                            Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                            cephalosporin- allergic patients

                                            Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                            Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                            bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                            CarbapenemGroup Classification

                                            Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                            Group 2 Broad-spectrum carbapenems with activity against non-

                                            fermentative Gram-negative bacilli (eg Pseudomonas

                                            Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                            Group3 Carbapenems with clinical activity against Methicillin-

                                            Resistant Staphylococcus (eg In development)

                                            J Antimicrob Chemotherapy

                                            Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                            especially old patients CRI preexisting seizure disorder or CNS pathology

                                            AminoglycosidesAminoglycosides

                                            Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                            - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                            mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                            Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                            DECREASES the rate of tissue uptake mdash DELAY the onset

                                            of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                            will eventually develop toxicity

                                            Fluoroquinolones

                                            Group I

                                            - Nalidixic acid

                                            - Enteric or urinary tract infections Group II

                                            - Ciprofloxacin Ofloxacin Levofloxacin

                                            - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                            - Moxifloxacin Gemifloxacin

                                            - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                            (P aeruginosadarr)

                                            - Respiratory tract infections

                                            GlycopeptidesGlycopeptides

                                            Vancomycin amp Teicoplanin

                                            Non-β-lactam cell wall synthesis inhibitor

                                            Spectrum GPC amp GPB

                                            Avoid oral use except AAC (antibiotic-associated colitis)

                                            Tetracyclines

                                            STD

                                            - Chlamydial

                                            diseases

                                            - Gonorrhea

                                            (doxycycline +

                                            ceftriaxone)

                                            - Syphilis

                                            Rickettsial diseases

                                            Brucellosis

                                            Tularemia

                                            Relapsing fever

                                            Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                            MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                            group Streptococcus pyogenes

                                            AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                            Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                            maltophilia

                                            Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                            Colistimethate sodium Colistimethate sodium Pseudomonas

                                            aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                            E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                            colistimethate 6 to 12 mgkg colistimethate sodium per

                                            day 60 kg man recommended dose for

                                            Colomycin is 240 to 480 mg of colistimethate sodium

                                            Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                            抗生素使用常見的五大錯誤

                                            Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                            bomb)

                                            Colonization

                                            Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                            Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                            抗生素使用的適應症

                                            明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                            常見感染症之抗生素療程 ( 一 )

                                            感染症療程 ( 天 )

                                            菌血症 敗血症 14

                                            肝膿瘍 21

                                            軟組織感染 7-10

                                            急性腎炎 14

                                            細菌性腦膜炎 10

                                            常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                            1048729

                                            肺炎雙球菌肺炎 14 ()

                                            革蘭氏陰性桿菌肺炎1048729

                                            21 ()

                                            退伍軍人協會症1048729

                                            21

                                            奴卡氏菌肺炎1048729

                                            180-360

                                            感染性心內膜炎 28-42

                                            抗生素治療失敗之原因

                                            選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                            • Slide 15
                                            • Slide 26
                                            • Slide 27
                                            • Slide 28

                                              Sulbactam (Maxtam)

                                              Sulbactam is an irreversible inhibitor of beta-lactamase

                                              Combinations of sulbactam with beta-lactam antibiotics

                                              Dose 05 ~ 10 gm 6 ~ 8 with other antibiotics not

                                              gt 40 gmday Cefoperazonesulbactam Ampicillinsulbactam

                                              Cephalosporins

                                              First generation Second generation Third generation Fourth generation

                                              Cephalosporins

                                              Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                              First Generation

                                              Cefazolin Cefadroxil Ceflexin Cephradine

                                              StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                              Second Generation

                                              Cefmetazole Cefuroxime

                                              Cefalor Cefuroxime

                                              above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                              Third generation

                                              Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                              Cefixime Cefpodoxime ceftibuten

                                              Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                              Fourth Generation

                                              Cefepime Cefpirome

                                              Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                              Adverse effects of cephalosporins

                                              Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                              Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                              cephalosporin- allergic patients

                                              Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                              Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                              bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                              CarbapenemGroup Classification

                                              Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                              Group 2 Broad-spectrum carbapenems with activity against non-

                                              fermentative Gram-negative bacilli (eg Pseudomonas

                                              Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                              Group3 Carbapenems with clinical activity against Methicillin-

                                              Resistant Staphylococcus (eg In development)

                                              J Antimicrob Chemotherapy

                                              Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                              especially old patients CRI preexisting seizure disorder or CNS pathology

                                              AminoglycosidesAminoglycosides

                                              Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                              - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                              mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                              Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                              DECREASES the rate of tissue uptake mdash DELAY the onset

                                              of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                              will eventually develop toxicity

                                              Fluoroquinolones

                                              Group I

                                              - Nalidixic acid

                                              - Enteric or urinary tract infections Group II

                                              - Ciprofloxacin Ofloxacin Levofloxacin

                                              - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                              - Moxifloxacin Gemifloxacin

                                              - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                              (P aeruginosadarr)

                                              - Respiratory tract infections

                                              GlycopeptidesGlycopeptides

                                              Vancomycin amp Teicoplanin

                                              Non-β-lactam cell wall synthesis inhibitor

                                              Spectrum GPC amp GPB

                                              Avoid oral use except AAC (antibiotic-associated colitis)

                                              Tetracyclines

                                              STD

                                              - Chlamydial

                                              diseases

                                              - Gonorrhea

                                              (doxycycline +

                                              ceftriaxone)

                                              - Syphilis

                                              Rickettsial diseases

                                              Brucellosis

                                              Tularemia

                                              Relapsing fever

                                              Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                              MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                              group Streptococcus pyogenes

                                              AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                              Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                              maltophilia

                                              Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                              Colistimethate sodium Colistimethate sodium Pseudomonas

                                              aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                              E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                              colistimethate 6 to 12 mgkg colistimethate sodium per

                                              day 60 kg man recommended dose for

                                              Colomycin is 240 to 480 mg of colistimethate sodium

                                              Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                              抗生素使用常見的五大錯誤

                                              Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                              bomb)

                                              Colonization

                                              Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                              Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                              抗生素使用的適應症

                                              明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                              常見感染症之抗生素療程 ( 一 )

                                              感染症療程 ( 天 )

                                              菌血症 敗血症 14

                                              肝膿瘍 21

                                              軟組織感染 7-10

                                              急性腎炎 14

                                              細菌性腦膜炎 10

                                              常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                              1048729

                                              肺炎雙球菌肺炎 14 ()

                                              革蘭氏陰性桿菌肺炎1048729

                                              21 ()

                                              退伍軍人協會症1048729

                                              21

                                              奴卡氏菌肺炎1048729

                                              180-360

                                              感染性心內膜炎 28-42

                                              抗生素治療失敗之原因

                                              選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                              • Slide 15
                                              • Slide 26
                                              • Slide 27
                                              • Slide 28

                                                Cephalosporins

                                                First generation Second generation Third generation Fourth generation

                                                Cephalosporins

                                                Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                                First Generation

                                                Cefazolin Cefadroxil Ceflexin Cephradine

                                                StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                                Second Generation

                                                Cefmetazole Cefuroxime

                                                Cefalor Cefuroxime

                                                above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                                Third generation

                                                Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                                Cefixime Cefpodoxime ceftibuten

                                                Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                                Fourth Generation

                                                Cefepime Cefpirome

                                                Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                                Adverse effects of cephalosporins

                                                Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                                Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                cephalosporin- allergic patients

                                                Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                CarbapenemGroup Classification

                                                Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                Group 2 Broad-spectrum carbapenems with activity against non-

                                                fermentative Gram-negative bacilli (eg Pseudomonas

                                                Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                Group3 Carbapenems with clinical activity against Methicillin-

                                                Resistant Staphylococcus (eg In development)

                                                J Antimicrob Chemotherapy

                                                Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                especially old patients CRI preexisting seizure disorder or CNS pathology

                                                AminoglycosidesAminoglycosides

                                                Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                DECREASES the rate of tissue uptake mdash DELAY the onset

                                                of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                will eventually develop toxicity

                                                Fluoroquinolones

                                                Group I

                                                - Nalidixic acid

                                                - Enteric or urinary tract infections Group II

                                                - Ciprofloxacin Ofloxacin Levofloxacin

                                                - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                - Moxifloxacin Gemifloxacin

                                                - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                (P aeruginosadarr)

                                                - Respiratory tract infections

                                                GlycopeptidesGlycopeptides

                                                Vancomycin amp Teicoplanin

                                                Non-β-lactam cell wall synthesis inhibitor

                                                Spectrum GPC amp GPB

                                                Avoid oral use except AAC (antibiotic-associated colitis)

                                                Tetracyclines

                                                STD

                                                - Chlamydial

                                                diseases

                                                - Gonorrhea

                                                (doxycycline +

                                                ceftriaxone)

                                                - Syphilis

                                                Rickettsial diseases

                                                Brucellosis

                                                Tularemia

                                                Relapsing fever

                                                Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                group Streptococcus pyogenes

                                                AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                maltophilia

                                                Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                Colistimethate sodium Colistimethate sodium Pseudomonas

                                                aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                colistimethate 6 to 12 mgkg colistimethate sodium per

                                                day 60 kg man recommended dose for

                                                Colomycin is 240 to 480 mg of colistimethate sodium

                                                Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                抗生素使用常見的五大錯誤

                                                Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                bomb)

                                                Colonization

                                                Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                抗生素使用的適應症

                                                明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                常見感染症之抗生素療程 ( 一 )

                                                感染症療程 ( 天 )

                                                菌血症 敗血症 14

                                                肝膿瘍 21

                                                軟組織感染 7-10

                                                急性腎炎 14

                                                細菌性腦膜炎 10

                                                常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                1048729

                                                肺炎雙球菌肺炎 14 ()

                                                革蘭氏陰性桿菌肺炎1048729

                                                21 ()

                                                退伍軍人協會症1048729

                                                21

                                                奴卡氏菌肺炎1048729

                                                180-360

                                                感染性心內膜炎 28-42

                                                抗生素治療失敗之原因

                                                選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                • Slide 15
                                                • Slide 26
                                                • Slide 27
                                                • Slide 28

                                                  Cephalosporins

                                                  Against GPC 1st gt 2nd gt cephamycins gt 3rd Against GNB 1st lt 2nd lt cephamycins lt 3rd

                                                  First Generation

                                                  Cefazolin Cefadroxil Ceflexin Cephradine

                                                  StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                                  Second Generation

                                                  Cefmetazole Cefuroxime

                                                  Cefalor Cefuroxime

                                                  above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                                  Third generation

                                                  Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                                  Cefixime Cefpodoxime ceftibuten

                                                  Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                                  Fourth Generation

                                                  Cefepime Cefpirome

                                                  Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                                  Adverse effects of cephalosporins

                                                  Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                                  Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                  cephalosporin- allergic patients

                                                  Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                  Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                  bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                  CarbapenemGroup Classification

                                                  Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                  Group 2 Broad-spectrum carbapenems with activity against non-

                                                  fermentative Gram-negative bacilli (eg Pseudomonas

                                                  Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                  Group3 Carbapenems with clinical activity against Methicillin-

                                                  Resistant Staphylococcus (eg In development)

                                                  J Antimicrob Chemotherapy

                                                  Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                  especially old patients CRI preexisting seizure disorder or CNS pathology

                                                  AminoglycosidesAminoglycosides

                                                  Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                  - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                  mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                  Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                  DECREASES the rate of tissue uptake mdash DELAY the onset

                                                  of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                  will eventually develop toxicity

                                                  Fluoroquinolones

                                                  Group I

                                                  - Nalidixic acid

                                                  - Enteric or urinary tract infections Group II

                                                  - Ciprofloxacin Ofloxacin Levofloxacin

                                                  - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                  - Moxifloxacin Gemifloxacin

                                                  - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                  (P aeruginosadarr)

                                                  - Respiratory tract infections

                                                  GlycopeptidesGlycopeptides

                                                  Vancomycin amp Teicoplanin

                                                  Non-β-lactam cell wall synthesis inhibitor

                                                  Spectrum GPC amp GPB

                                                  Avoid oral use except AAC (antibiotic-associated colitis)

                                                  Tetracyclines

                                                  STD

                                                  - Chlamydial

                                                  diseases

                                                  - Gonorrhea

                                                  (doxycycline +

                                                  ceftriaxone)

                                                  - Syphilis

                                                  Rickettsial diseases

                                                  Brucellosis

                                                  Tularemia

                                                  Relapsing fever

                                                  Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                  MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                  group Streptococcus pyogenes

                                                  AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                  Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                  maltophilia

                                                  Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                  Colistimethate sodium Colistimethate sodium Pseudomonas

                                                  aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                  E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                  colistimethate 6 to 12 mgkg colistimethate sodium per

                                                  day 60 kg man recommended dose for

                                                  Colomycin is 240 to 480 mg of colistimethate sodium

                                                  Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                  抗生素使用常見的五大錯誤

                                                  Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                  bomb)

                                                  Colonization

                                                  Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                  Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                  抗生素使用的適應症

                                                  明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                  常見感染症之抗生素療程 ( 一 )

                                                  感染症療程 ( 天 )

                                                  菌血症 敗血症 14

                                                  肝膿瘍 21

                                                  軟組織感染 7-10

                                                  急性腎炎 14

                                                  細菌性腦膜炎 10

                                                  常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                  1048729

                                                  肺炎雙球菌肺炎 14 ()

                                                  革蘭氏陰性桿菌肺炎1048729

                                                  21 ()

                                                  退伍軍人協會症1048729

                                                  21

                                                  奴卡氏菌肺炎1048729

                                                  180-360

                                                  感染性心內膜炎 28-42

                                                  抗生素治療失敗之原因

                                                  選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                  • Slide 15
                                                  • Slide 26
                                                  • Slide 27
                                                  • Slide 28

                                                    First Generation

                                                    Cefazolin Cefadroxil Ceflexin Cephradine

                                                    StreptococcusStaphylococcus (methicillin-susceptible)E coliP mirabilisK pneumoniae

                                                    Second Generation

                                                    Cefmetazole Cefuroxime

                                                    Cefalor Cefuroxime

                                                    above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                                    Third generation

                                                    Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                                    Cefixime Cefpodoxime ceftibuten

                                                    Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                                    Fourth Generation

                                                    Cefepime Cefpirome

                                                    Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                                    Adverse effects of cephalosporins

                                                    Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                                    Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                    cephalosporin- allergic patients

                                                    Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                    Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                    bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                    CarbapenemGroup Classification

                                                    Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                    Group 2 Broad-spectrum carbapenems with activity against non-

                                                    fermentative Gram-negative bacilli (eg Pseudomonas

                                                    Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                    Group3 Carbapenems with clinical activity against Methicillin-

                                                    Resistant Staphylococcus (eg In development)

                                                    J Antimicrob Chemotherapy

                                                    Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                    especially old patients CRI preexisting seizure disorder or CNS pathology

                                                    AminoglycosidesAminoglycosides

                                                    Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                    - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                    mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                    Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                    DECREASES the rate of tissue uptake mdash DELAY the onset

                                                    of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                    will eventually develop toxicity

                                                    Fluoroquinolones

                                                    Group I

                                                    - Nalidixic acid

                                                    - Enteric or urinary tract infections Group II

                                                    - Ciprofloxacin Ofloxacin Levofloxacin

                                                    - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                    - Moxifloxacin Gemifloxacin

                                                    - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                    (P aeruginosadarr)

                                                    - Respiratory tract infections

                                                    GlycopeptidesGlycopeptides

                                                    Vancomycin amp Teicoplanin

                                                    Non-β-lactam cell wall synthesis inhibitor

                                                    Spectrum GPC amp GPB

                                                    Avoid oral use except AAC (antibiotic-associated colitis)

                                                    Tetracyclines

                                                    STD

                                                    - Chlamydial

                                                    diseases

                                                    - Gonorrhea

                                                    (doxycycline +

                                                    ceftriaxone)

                                                    - Syphilis

                                                    Rickettsial diseases

                                                    Brucellosis

                                                    Tularemia

                                                    Relapsing fever

                                                    Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                    MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                    group Streptococcus pyogenes

                                                    AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                    Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                    maltophilia

                                                    Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                    Colistimethate sodium Colistimethate sodium Pseudomonas

                                                    aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                    E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                    colistimethate 6 to 12 mgkg colistimethate sodium per

                                                    day 60 kg man recommended dose for

                                                    Colomycin is 240 to 480 mg of colistimethate sodium

                                                    Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                    抗生素使用常見的五大錯誤

                                                    Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                    bomb)

                                                    Colonization

                                                    Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                    Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                    抗生素使用的適應症

                                                    明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                    常見感染症之抗生素療程 ( 一 )

                                                    感染症療程 ( 天 )

                                                    菌血症 敗血症 14

                                                    肝膿瘍 21

                                                    軟組織感染 7-10

                                                    急性腎炎 14

                                                    細菌性腦膜炎 10

                                                    常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                    1048729

                                                    肺炎雙球菌肺炎 14 ()

                                                    革蘭氏陰性桿菌肺炎1048729

                                                    21 ()

                                                    退伍軍人協會症1048729

                                                    21

                                                    奴卡氏菌肺炎1048729

                                                    180-360

                                                    感染性心內膜炎 28-42

                                                    抗生素治療失敗之原因

                                                    選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                    • Slide 15
                                                    • Slide 26
                                                    • Slide 27
                                                    • Slide 28

                                                      Second Generation

                                                      Cefmetazole Cefuroxime

                                                      Cefalor Cefuroxime

                                                      above the diaphragm cefuroximebelow the diaphragm cefmetazole (cephamycins B fragilis) Cefmatazole ESBL-producing Enterobacteriaceae

                                                      Third generation

                                                      Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                                      Cefixime Cefpodoxime ceftibuten

                                                      Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                                      Fourth Generation

                                                      Cefepime Cefpirome

                                                      Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                                      Adverse effects of cephalosporins

                                                      Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                                      Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                      cephalosporin- allergic patients

                                                      Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                      Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                      bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                      CarbapenemGroup Classification

                                                      Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                      Group 2 Broad-spectrum carbapenems with activity against non-

                                                      fermentative Gram-negative bacilli (eg Pseudomonas

                                                      Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                      Group3 Carbapenems with clinical activity against Methicillin-

                                                      Resistant Staphylococcus (eg In development)

                                                      J Antimicrob Chemotherapy

                                                      Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                      especially old patients CRI preexisting seizure disorder or CNS pathology

                                                      AminoglycosidesAminoglycosides

                                                      Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                      - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                      mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                      Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                      DECREASES the rate of tissue uptake mdash DELAY the onset

                                                      of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                      will eventually develop toxicity

                                                      Fluoroquinolones

                                                      Group I

                                                      - Nalidixic acid

                                                      - Enteric or urinary tract infections Group II

                                                      - Ciprofloxacin Ofloxacin Levofloxacin

                                                      - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                      - Moxifloxacin Gemifloxacin

                                                      - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                      (P aeruginosadarr)

                                                      - Respiratory tract infections

                                                      GlycopeptidesGlycopeptides

                                                      Vancomycin amp Teicoplanin

                                                      Non-β-lactam cell wall synthesis inhibitor

                                                      Spectrum GPC amp GPB

                                                      Avoid oral use except AAC (antibiotic-associated colitis)

                                                      Tetracyclines

                                                      STD

                                                      - Chlamydial

                                                      diseases

                                                      - Gonorrhea

                                                      (doxycycline +

                                                      ceftriaxone)

                                                      - Syphilis

                                                      Rickettsial diseases

                                                      Brucellosis

                                                      Tularemia

                                                      Relapsing fever

                                                      Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                      MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                      group Streptococcus pyogenes

                                                      AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                      Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                      maltophilia

                                                      Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                      Colistimethate sodium Colistimethate sodium Pseudomonas

                                                      aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                      E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                      colistimethate 6 to 12 mgkg colistimethate sodium per

                                                      day 60 kg man recommended dose for

                                                      Colomycin is 240 to 480 mg of colistimethate sodium

                                                      Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                      抗生素使用常見的五大錯誤

                                                      Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                      bomb)

                                                      Colonization

                                                      Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                      Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                      抗生素使用的適應症

                                                      明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                      常見感染症之抗生素療程 ( 一 )

                                                      感染症療程 ( 天 )

                                                      菌血症 敗血症 14

                                                      肝膿瘍 21

                                                      軟組織感染 7-10

                                                      急性腎炎 14

                                                      細菌性腦膜炎 10

                                                      常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                      1048729

                                                      肺炎雙球菌肺炎 14 ()

                                                      革蘭氏陰性桿菌肺炎1048729

                                                      21 ()

                                                      退伍軍人協會症1048729

                                                      21

                                                      奴卡氏菌肺炎1048729

                                                      180-360

                                                      感染性心內膜炎 28-42

                                                      抗生素治療失敗之原因

                                                      選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                      • Slide 15
                                                      • Slide 26
                                                      • Slide 27
                                                      • Slide 28

                                                        Third generation

                                                        Cefoperazone Cefotaxime Ceftazidime Ceftriaxone Flumarin

                                                        Cefixime Cefpodoxime ceftibuten

                                                        Resistant Gram-negative microorganisms ( Nosocomial infections ) Serratia Citrobacter Enterobacter Pseudomonas β-lactamase producing H influenzaeBetter BBB penetration among cephalosporins (except cefoperazone)Indication nosocomial infections (mainly GNB) GNB meningitis

                                                        Fourth Generation

                                                        Cefepime Cefpirome

                                                        Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                                        Adverse effects of cephalosporins

                                                        Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                                        Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                        cephalosporin- allergic patients

                                                        Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                        Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                        bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                        CarbapenemGroup Classification

                                                        Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                        Group 2 Broad-spectrum carbapenems with activity against non-

                                                        fermentative Gram-negative bacilli (eg Pseudomonas

                                                        Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                        Group3 Carbapenems with clinical activity against Methicillin-

                                                        Resistant Staphylococcus (eg In development)

                                                        J Antimicrob Chemotherapy

                                                        Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                        especially old patients CRI preexisting seizure disorder or CNS pathology

                                                        AminoglycosidesAminoglycosides

                                                        Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                        - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                        mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                        Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                        DECREASES the rate of tissue uptake mdash DELAY the onset

                                                        of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                        will eventually develop toxicity

                                                        Fluoroquinolones

                                                        Group I

                                                        - Nalidixic acid

                                                        - Enteric or urinary tract infections Group II

                                                        - Ciprofloxacin Ofloxacin Levofloxacin

                                                        - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                        - Moxifloxacin Gemifloxacin

                                                        - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                        (P aeruginosadarr)

                                                        - Respiratory tract infections

                                                        GlycopeptidesGlycopeptides

                                                        Vancomycin amp Teicoplanin

                                                        Non-β-lactam cell wall synthesis inhibitor

                                                        Spectrum GPC amp GPB

                                                        Avoid oral use except AAC (antibiotic-associated colitis)

                                                        Tetracyclines

                                                        STD

                                                        - Chlamydial

                                                        diseases

                                                        - Gonorrhea

                                                        (doxycycline +

                                                        ceftriaxone)

                                                        - Syphilis

                                                        Rickettsial diseases

                                                        Brucellosis

                                                        Tularemia

                                                        Relapsing fever

                                                        Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                        MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                        group Streptococcus pyogenes

                                                        AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                        Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                        maltophilia

                                                        Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                        Colistimethate sodium Colistimethate sodium Pseudomonas

                                                        aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                        E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                        colistimethate 6 to 12 mgkg colistimethate sodium per

                                                        day 60 kg man recommended dose for

                                                        Colomycin is 240 to 480 mg of colistimethate sodium

                                                        Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                        抗生素使用常見的五大錯誤

                                                        Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                        bomb)

                                                        Colonization

                                                        Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                        Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                        抗生素使用的適應症

                                                        明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                        常見感染症之抗生素療程 ( 一 )

                                                        感染症療程 ( 天 )

                                                        菌血症 敗血症 14

                                                        肝膿瘍 21

                                                        軟組織感染 7-10

                                                        急性腎炎 14

                                                        細菌性腦膜炎 10

                                                        常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                        1048729

                                                        肺炎雙球菌肺炎 14 ()

                                                        革蘭氏陰性桿菌肺炎1048729

                                                        21 ()

                                                        退伍軍人協會症1048729

                                                        21

                                                        奴卡氏菌肺炎1048729

                                                        180-360

                                                        感染性心內膜炎 28-42

                                                        抗生素治療失敗之原因

                                                        選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                        • Slide 15
                                                        • Slide 26
                                                        • Slide 27
                                                        • Slide 28

                                                          Fourth Generation

                                                          Cefepime Cefpirome

                                                          Good anti-pseudomonal effectGood CNS penetrationPreserve antimicrobial effect to G(+) bacteria

                                                          Adverse effects of cephalosporins

                                                          Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                                          Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                          cephalosporin- allergic patients

                                                          Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                          Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                          bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                          CarbapenemGroup Classification

                                                          Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                          Group 2 Broad-spectrum carbapenems with activity against non-

                                                          fermentative Gram-negative bacilli (eg Pseudomonas

                                                          Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                          Group3 Carbapenems with clinical activity against Methicillin-

                                                          Resistant Staphylococcus (eg In development)

                                                          J Antimicrob Chemotherapy

                                                          Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                          especially old patients CRI preexisting seizure disorder or CNS pathology

                                                          AminoglycosidesAminoglycosides

                                                          Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                          - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                          mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                          Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                          DECREASES the rate of tissue uptake mdash DELAY the onset

                                                          of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                          will eventually develop toxicity

                                                          Fluoroquinolones

                                                          Group I

                                                          - Nalidixic acid

                                                          - Enteric or urinary tract infections Group II

                                                          - Ciprofloxacin Ofloxacin Levofloxacin

                                                          - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                          - Moxifloxacin Gemifloxacin

                                                          - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                          (P aeruginosadarr)

                                                          - Respiratory tract infections

                                                          GlycopeptidesGlycopeptides

                                                          Vancomycin amp Teicoplanin

                                                          Non-β-lactam cell wall synthesis inhibitor

                                                          Spectrum GPC amp GPB

                                                          Avoid oral use except AAC (antibiotic-associated colitis)

                                                          Tetracyclines

                                                          STD

                                                          - Chlamydial

                                                          diseases

                                                          - Gonorrhea

                                                          (doxycycline +

                                                          ceftriaxone)

                                                          - Syphilis

                                                          Rickettsial diseases

                                                          Brucellosis

                                                          Tularemia

                                                          Relapsing fever

                                                          Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                          MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                          group Streptococcus pyogenes

                                                          AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                          Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                          maltophilia

                                                          Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                          Colistimethate sodium Colistimethate sodium Pseudomonas

                                                          aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                          E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                          colistimethate 6 to 12 mgkg colistimethate sodium per

                                                          day 60 kg man recommended dose for

                                                          Colomycin is 240 to 480 mg of colistimethate sodium

                                                          Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                          抗生素使用常見的五大錯誤

                                                          Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                          bomb)

                                                          Colonization

                                                          Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                          Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                          抗生素使用的適應症

                                                          明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                          常見感染症之抗生素療程 ( 一 )

                                                          感染症療程 ( 天 )

                                                          菌血症 敗血症 14

                                                          肝膿瘍 21

                                                          軟組織感染 7-10

                                                          急性腎炎 14

                                                          細菌性腦膜炎 10

                                                          常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                          1048729

                                                          肺炎雙球菌肺炎 14 ()

                                                          革蘭氏陰性桿菌肺炎1048729

                                                          21 ()

                                                          退伍軍人協會症1048729

                                                          21

                                                          奴卡氏菌肺炎1048729

                                                          180-360

                                                          感染性心內膜炎 28-42

                                                          抗生素治療失敗之原因

                                                          選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                          • Slide 15
                                                          • Slide 26
                                                          • Slide 27
                                                          • Slide 28

                                                            Adverse effects of cephalosporins

                                                            Cefamandole cefmetazole cefoperazone cefotetan vitamin K-dependent clotting factor metabolism

                                                            Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                            cephalosporin- allergic patients

                                                            Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                            Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                            bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                            CarbapenemGroup Classification

                                                            Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                            Group 2 Broad-spectrum carbapenems with activity against non-

                                                            fermentative Gram-negative bacilli (eg Pseudomonas

                                                            Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                            Group3 Carbapenems with clinical activity against Methicillin-

                                                            Resistant Staphylococcus (eg In development)

                                                            J Antimicrob Chemotherapy

                                                            Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                            especially old patients CRI preexisting seizure disorder or CNS pathology

                                                            AminoglycosidesAminoglycosides

                                                            Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                            - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                            mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                            Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                            DECREASES the rate of tissue uptake mdash DELAY the onset

                                                            of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                            will eventually develop toxicity

                                                            Fluoroquinolones

                                                            Group I

                                                            - Nalidixic acid

                                                            - Enteric or urinary tract infections Group II

                                                            - Ciprofloxacin Ofloxacin Levofloxacin

                                                            - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                            - Moxifloxacin Gemifloxacin

                                                            - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                            (P aeruginosadarr)

                                                            - Respiratory tract infections

                                                            GlycopeptidesGlycopeptides

                                                            Vancomycin amp Teicoplanin

                                                            Non-β-lactam cell wall synthesis inhibitor

                                                            Spectrum GPC amp GPB

                                                            Avoid oral use except AAC (antibiotic-associated colitis)

                                                            Tetracyclines

                                                            STD

                                                            - Chlamydial

                                                            diseases

                                                            - Gonorrhea

                                                            (doxycycline +

                                                            ceftriaxone)

                                                            - Syphilis

                                                            Rickettsial diseases

                                                            Brucellosis

                                                            Tularemia

                                                            Relapsing fever

                                                            Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                            MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                            group Streptococcus pyogenes

                                                            AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                            Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                            maltophilia

                                                            Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                            Colistimethate sodium Colistimethate sodium Pseudomonas

                                                            aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                            E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                            colistimethate 6 to 12 mgkg colistimethate sodium per

                                                            day 60 kg man recommended dose for

                                                            Colomycin is 240 to 480 mg of colistimethate sodium

                                                            Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                            抗生素使用常見的五大錯誤

                                                            Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                            bomb)

                                                            Colonization

                                                            Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                            Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                            抗生素使用的適應症

                                                            明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                            常見感染症之抗生素療程 ( 一 )

                                                            感染症療程 ( 天 )

                                                            菌血症 敗血症 14

                                                            肝膿瘍 21

                                                            軟組織感染 7-10

                                                            急性腎炎 14

                                                            細菌性腦膜炎 10

                                                            常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                            1048729

                                                            肺炎雙球菌肺炎 14 ()

                                                            革蘭氏陰性桿菌肺炎1048729

                                                            21 ()

                                                            退伍軍人協會症1048729

                                                            21

                                                            奴卡氏菌肺炎1048729

                                                            180-360

                                                            感染性心內膜炎 28-42

                                                            抗生素治療失敗之原因

                                                            選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                            • Slide 15
                                                            • Slide 26
                                                            • Slide 27
                                                            • Slide 28

                                                              Monobactam Monobactam (Aztreonam(Aztreonam)) Only gram-negative aerobes Alternative in penicillin- and

                                                              cephalosporin- allergic patients

                                                              Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                              Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                              bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                              CarbapenemGroup Classification

                                                              Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                              Group 2 Broad-spectrum carbapenems with activity against non-

                                                              fermentative Gram-negative bacilli (eg Pseudomonas

                                                              Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                              Group3 Carbapenems with clinical activity against Methicillin-

                                                              Resistant Staphylococcus (eg In development)

                                                              J Antimicrob Chemotherapy

                                                              Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                              especially old patients CRI preexisting seizure disorder or CNS pathology

                                                              AminoglycosidesAminoglycosides

                                                              Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                              - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                              mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                              Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                              DECREASES the rate of tissue uptake mdash DELAY the onset

                                                              of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                              will eventually develop toxicity

                                                              Fluoroquinolones

                                                              Group I

                                                              - Nalidixic acid

                                                              - Enteric or urinary tract infections Group II

                                                              - Ciprofloxacin Ofloxacin Levofloxacin

                                                              - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                              - Moxifloxacin Gemifloxacin

                                                              - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                              (P aeruginosadarr)

                                                              - Respiratory tract infections

                                                              GlycopeptidesGlycopeptides

                                                              Vancomycin amp Teicoplanin

                                                              Non-β-lactam cell wall synthesis inhibitor

                                                              Spectrum GPC amp GPB

                                                              Avoid oral use except AAC (antibiotic-associated colitis)

                                                              Tetracyclines

                                                              STD

                                                              - Chlamydial

                                                              diseases

                                                              - Gonorrhea

                                                              (doxycycline +

                                                              ceftriaxone)

                                                              - Syphilis

                                                              Rickettsial diseases

                                                              Brucellosis

                                                              Tularemia

                                                              Relapsing fever

                                                              Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                              MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                              group Streptococcus pyogenes

                                                              AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                              Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                              maltophilia

                                                              Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                              Colistimethate sodium Colistimethate sodium Pseudomonas

                                                              aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                              E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                              colistimethate 6 to 12 mgkg colistimethate sodium per

                                                              day 60 kg man recommended dose for

                                                              Colomycin is 240 to 480 mg of colistimethate sodium

                                                              Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                              抗生素使用常見的五大錯誤

                                                              Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                              bomb)

                                                              Colonization

                                                              Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                              Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                              抗生素使用的適應症

                                                              明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                              常見感染症之抗生素療程 ( 一 )

                                                              感染症療程 ( 天 )

                                                              菌血症 敗血症 14

                                                              肝膿瘍 21

                                                              軟組織感染 7-10

                                                              急性腎炎 14

                                                              細菌性腦膜炎 10

                                                              常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                              1048729

                                                              肺炎雙球菌肺炎 14 ()

                                                              革蘭氏陰性桿菌肺炎1048729

                                                              21 ()

                                                              退伍軍人協會症1048729

                                                              21

                                                              奴卡氏菌肺炎1048729

                                                              180-360

                                                              感染性心內膜炎 28-42

                                                              抗生素治療失敗之原因

                                                              選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                              • Slide 15
                                                              • Slide 26
                                                              • Slide 27
                                                              • Slide 28

                                                                Sulfonamides and trimethoprim Inhibit folic acid metabolism Treatment of PCP Nocardia

                                                                Toxaplasma Sternotrophomonus Aderverse effect cholestatic jaudice

                                                                bone marrow suppression severe hypersensitivity (Stevens-Johnson syndrome)

                                                                CarbapenemGroup Classification

                                                                Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                                Group 2 Broad-spectrum carbapenems with activity against non-

                                                                fermentative Gram-negative bacilli (eg Pseudomonas

                                                                Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                                Group3 Carbapenems with clinical activity against Methicillin-

                                                                Resistant Staphylococcus (eg In development)

                                                                J Antimicrob Chemotherapy

                                                                Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                                especially old patients CRI preexisting seizure disorder or CNS pathology

                                                                AminoglycosidesAminoglycosides

                                                                Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                                - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                                mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                                Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                                DECREASES the rate of tissue uptake mdash DELAY the onset

                                                                of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                                will eventually develop toxicity

                                                                Fluoroquinolones

                                                                Group I

                                                                - Nalidixic acid

                                                                - Enteric or urinary tract infections Group II

                                                                - Ciprofloxacin Ofloxacin Levofloxacin

                                                                - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                                - Moxifloxacin Gemifloxacin

                                                                - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                                (P aeruginosadarr)

                                                                - Respiratory tract infections

                                                                GlycopeptidesGlycopeptides

                                                                Vancomycin amp Teicoplanin

                                                                Non-β-lactam cell wall synthesis inhibitor

                                                                Spectrum GPC amp GPB

                                                                Avoid oral use except AAC (antibiotic-associated colitis)

                                                                Tetracyclines

                                                                STD

                                                                - Chlamydial

                                                                diseases

                                                                - Gonorrhea

                                                                (doxycycline +

                                                                ceftriaxone)

                                                                - Syphilis

                                                                Rickettsial diseases

                                                                Brucellosis

                                                                Tularemia

                                                                Relapsing fever

                                                                Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                group Streptococcus pyogenes

                                                                AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                maltophilia

                                                                Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                day 60 kg man recommended dose for

                                                                Colomycin is 240 to 480 mg of colistimethate sodium

                                                                Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                抗生素使用常見的五大錯誤

                                                                Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                bomb)

                                                                Colonization

                                                                Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                抗生素使用的適應症

                                                                明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                常見感染症之抗生素療程 ( 一 )

                                                                感染症療程 ( 天 )

                                                                菌血症 敗血症 14

                                                                肝膿瘍 21

                                                                軟組織感染 7-10

                                                                急性腎炎 14

                                                                細菌性腦膜炎 10

                                                                常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                1048729

                                                                肺炎雙球菌肺炎 14 ()

                                                                革蘭氏陰性桿菌肺炎1048729

                                                                21 ()

                                                                退伍軍人協會症1048729

                                                                21

                                                                奴卡氏菌肺炎1048729

                                                                180-360

                                                                感染性心內膜炎 28-42

                                                                抗生素治療失敗之原因

                                                                選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                • Slide 15
                                                                • Slide 26
                                                                • Slide 27
                                                                • Slide 28

                                                                  CarbapenemGroup Classification

                                                                  Group 1 Broad-spectrum carbapenems with limited activity against non-fermentative Gram-negative bacilli (NFGNB eg Pseudomonas Acinetobacter) that are particularly suitable for community-acquired infections (eg ertapenem)

                                                                  Group 2 Broad-spectrum carbapenems with activity against non-

                                                                  fermentative Gram-negative bacilli (eg Pseudomonas

                                                                  Acinetobacter) that are particularly suitable for nosocomial infections (eg imipenem and meropenem)

                                                                  Group3 Carbapenems with clinical activity against Methicillin-

                                                                  Resistant Staphylococcus (eg In development)

                                                                  J Antimicrob Chemotherapy

                                                                  Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                                  especially old patients CRI preexisting seizure disorder or CNS pathology

                                                                  AminoglycosidesAminoglycosides

                                                                  Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                                  - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                                  mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                                  Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                                  DECREASES the rate of tissue uptake mdash DELAY the onset

                                                                  of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                                  will eventually develop toxicity

                                                                  Fluoroquinolones

                                                                  Group I

                                                                  - Nalidixic acid

                                                                  - Enteric or urinary tract infections Group II

                                                                  - Ciprofloxacin Ofloxacin Levofloxacin

                                                                  - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                                  - Moxifloxacin Gemifloxacin

                                                                  - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                                  (P aeruginosadarr)

                                                                  - Respiratory tract infections

                                                                  GlycopeptidesGlycopeptides

                                                                  Vancomycin amp Teicoplanin

                                                                  Non-β-lactam cell wall synthesis inhibitor

                                                                  Spectrum GPC amp GPB

                                                                  Avoid oral use except AAC (antibiotic-associated colitis)

                                                                  Tetracyclines

                                                                  STD

                                                                  - Chlamydial

                                                                  diseases

                                                                  - Gonorrhea

                                                                  (doxycycline +

                                                                  ceftriaxone)

                                                                  - Syphilis

                                                                  Rickettsial diseases

                                                                  Brucellosis

                                                                  Tularemia

                                                                  Relapsing fever

                                                                  Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                  MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                  group Streptococcus pyogenes

                                                                  AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                  Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                  maltophilia

                                                                  Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                  Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                  aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                  E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                  colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                  day 60 kg man recommended dose for

                                                                  Colomycin is 240 to 480 mg of colistimethate sodium

                                                                  Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                  抗生素使用常見的五大錯誤

                                                                  Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                  bomb)

                                                                  Colonization

                                                                  Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                  Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                  抗生素使用的適應症

                                                                  明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                  常見感染症之抗生素療程 ( 一 )

                                                                  感染症療程 ( 天 )

                                                                  菌血症 敗血症 14

                                                                  肝膿瘍 21

                                                                  軟組織感染 7-10

                                                                  急性腎炎 14

                                                                  細菌性腦膜炎 10

                                                                  常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                  1048729

                                                                  肺炎雙球菌肺炎 14 ()

                                                                  革蘭氏陰性桿菌肺炎1048729

                                                                  21 ()

                                                                  退伍軍人協會症1048729

                                                                  21

                                                                  奴卡氏菌肺炎1048729

                                                                  180-360

                                                                  感染性心內膜炎 28-42

                                                                  抗生素治療失敗之原因

                                                                  選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                  • Slide 15
                                                                  • Slide 26
                                                                  • Slide 27
                                                                  • Slide 28

                                                                    Side effect of Carbapenems Anaphylaxis Interstitial nephritis Anemia Leukopenia Precipitate seizure activity

                                                                    especially old patients CRI preexisting seizure disorder or CNS pathology

                                                                    AminoglycosidesAminoglycosides

                                                                    Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                                    - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                                    mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                                    Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                                    DECREASES the rate of tissue uptake mdash DELAY the onset

                                                                    of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                                    will eventually develop toxicity

                                                                    Fluoroquinolones

                                                                    Group I

                                                                    - Nalidixic acid

                                                                    - Enteric or urinary tract infections Group II

                                                                    - Ciprofloxacin Ofloxacin Levofloxacin

                                                                    - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                                    - Moxifloxacin Gemifloxacin

                                                                    - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                                    (P aeruginosadarr)

                                                                    - Respiratory tract infections

                                                                    GlycopeptidesGlycopeptides

                                                                    Vancomycin amp Teicoplanin

                                                                    Non-β-lactam cell wall synthesis inhibitor

                                                                    Spectrum GPC amp GPB

                                                                    Avoid oral use except AAC (antibiotic-associated colitis)

                                                                    Tetracyclines

                                                                    STD

                                                                    - Chlamydial

                                                                    diseases

                                                                    - Gonorrhea

                                                                    (doxycycline +

                                                                    ceftriaxone)

                                                                    - Syphilis

                                                                    Rickettsial diseases

                                                                    Brucellosis

                                                                    Tularemia

                                                                    Relapsing fever

                                                                    Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                    MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                    group Streptococcus pyogenes

                                                                    AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                    Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                    maltophilia

                                                                    Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                    Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                    aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                    E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                    colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                    day 60 kg man recommended dose for

                                                                    Colomycin is 240 to 480 mg of colistimethate sodium

                                                                    Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                    抗生素使用常見的五大錯誤

                                                                    Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                    bomb)

                                                                    Colonization

                                                                    Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                    Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                    抗生素使用的適應症

                                                                    明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                    常見感染症之抗生素療程 ( 一 )

                                                                    感染症療程 ( 天 )

                                                                    菌血症 敗血症 14

                                                                    肝膿瘍 21

                                                                    軟組織感染 7-10

                                                                    急性腎炎 14

                                                                    細菌性腦膜炎 10

                                                                    常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                    1048729

                                                                    肺炎雙球菌肺炎 14 ()

                                                                    革蘭氏陰性桿菌肺炎1048729

                                                                    21 ()

                                                                    退伍軍人協會症1048729

                                                                    21

                                                                    奴卡氏菌肺炎1048729

                                                                    180-360

                                                                    感染性心內膜炎 28-42

                                                                    抗生素治療失敗之原因

                                                                    選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                    • Slide 15
                                                                    • Slide 26
                                                                    • Slide 27
                                                                    • Slide 28

                                                                      AminoglycosidesAminoglycosides

                                                                      Antimicrobial Spectrum Antimicrobial Spectrum - All Gram negative bacilli

                                                                      - Staphylococcus aureus Dosage Dosage - Gentamicin loading ~ 2 mgkg maintenance ~ 3-5 mgkgday Amikacin loading ~ 75 mgkg maintenance ~ 5 mgkg Q8H or 75

                                                                      mgkg q12H Exacin 8mgskgday Single daily (once-daily) dosing (SDD) Short course (3-5 days)

                                                                      Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                                      DECREASES the rate of tissue uptake mdash DELAY the onset

                                                                      of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                                      will eventually develop toxicity

                                                                      Fluoroquinolones

                                                                      Group I

                                                                      - Nalidixic acid

                                                                      - Enteric or urinary tract infections Group II

                                                                      - Ciprofloxacin Ofloxacin Levofloxacin

                                                                      - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                                      - Moxifloxacin Gemifloxacin

                                                                      - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                                      (P aeruginosadarr)

                                                                      - Respiratory tract infections

                                                                      GlycopeptidesGlycopeptides

                                                                      Vancomycin amp Teicoplanin

                                                                      Non-β-lactam cell wall synthesis inhibitor

                                                                      Spectrum GPC amp GPB

                                                                      Avoid oral use except AAC (antibiotic-associated colitis)

                                                                      Tetracyclines

                                                                      STD

                                                                      - Chlamydial

                                                                      diseases

                                                                      - Gonorrhea

                                                                      (doxycycline +

                                                                      ceftriaxone)

                                                                      - Syphilis

                                                                      Rickettsial diseases

                                                                      Brucellosis

                                                                      Tularemia

                                                                      Relapsing fever

                                                                      Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                      MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                      group Streptococcus pyogenes

                                                                      AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                      Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                      maltophilia

                                                                      Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                      Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                      aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                      E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                      colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                      day 60 kg man recommended dose for

                                                                      Colomycin is 240 to 480 mg of colistimethate sodium

                                                                      Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                      抗生素使用常見的五大錯誤

                                                                      Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                      bomb)

                                                                      Colonization

                                                                      Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                      Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                      抗生素使用的適應症

                                                                      明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                      常見感染症之抗生素療程 ( 一 )

                                                                      感染症療程 ( 天 )

                                                                      菌血症 敗血症 14

                                                                      肝膿瘍 21

                                                                      軟組織感染 7-10

                                                                      急性腎炎 14

                                                                      細菌性腦膜炎 10

                                                                      常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                      1048729

                                                                      肺炎雙球菌肺炎 14 ()

                                                                      革蘭氏陰性桿菌肺炎1048729

                                                                      21 ()

                                                                      退伍軍人協會症1048729

                                                                      21

                                                                      奴卡氏菌肺炎1048729

                                                                      180-360

                                                                      感染性心內膜炎 28-42

                                                                      抗生素治療失敗之原因

                                                                      選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                      • Slide 15
                                                                      • Slide 26
                                                                      • Slide 27
                                                                      • Slide 28

                                                                        Adverse effects of Adverse effects of aminoglycosidesaminoglycosides Nephrotoxicity Ototoxicity Neuromuscular paralysis ~ High doseinfrequent administration

                                                                        DECREASES the rate of tissue uptake mdash DELAY the onset

                                                                        of toxicity doesnrsquot prevent it from happening ~ All patients if treated for a long enough time

                                                                        will eventually develop toxicity

                                                                        Fluoroquinolones

                                                                        Group I

                                                                        - Nalidixic acid

                                                                        - Enteric or urinary tract infections Group II

                                                                        - Ciprofloxacin Ofloxacin Levofloxacin

                                                                        - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                                        - Moxifloxacin Gemifloxacin

                                                                        - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                                        (P aeruginosadarr)

                                                                        - Respiratory tract infections

                                                                        GlycopeptidesGlycopeptides

                                                                        Vancomycin amp Teicoplanin

                                                                        Non-β-lactam cell wall synthesis inhibitor

                                                                        Spectrum GPC amp GPB

                                                                        Avoid oral use except AAC (antibiotic-associated colitis)

                                                                        Tetracyclines

                                                                        STD

                                                                        - Chlamydial

                                                                        diseases

                                                                        - Gonorrhea

                                                                        (doxycycline +

                                                                        ceftriaxone)

                                                                        - Syphilis

                                                                        Rickettsial diseases

                                                                        Brucellosis

                                                                        Tularemia

                                                                        Relapsing fever

                                                                        Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                        MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                        group Streptococcus pyogenes

                                                                        AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                        Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                        maltophilia

                                                                        Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                        Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                        aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                        E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                        colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                        day 60 kg man recommended dose for

                                                                        Colomycin is 240 to 480 mg of colistimethate sodium

                                                                        Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                        抗生素使用常見的五大錯誤

                                                                        Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                        bomb)

                                                                        Colonization

                                                                        Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                        Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                        抗生素使用的適應症

                                                                        明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                        常見感染症之抗生素療程 ( 一 )

                                                                        感染症療程 ( 天 )

                                                                        菌血症 敗血症 14

                                                                        肝膿瘍 21

                                                                        軟組織感染 7-10

                                                                        急性腎炎 14

                                                                        細菌性腦膜炎 10

                                                                        常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                        1048729

                                                                        肺炎雙球菌肺炎 14 ()

                                                                        革蘭氏陰性桿菌肺炎1048729

                                                                        21 ()

                                                                        退伍軍人協會症1048729

                                                                        21

                                                                        奴卡氏菌肺炎1048729

                                                                        180-360

                                                                        感染性心內膜炎 28-42

                                                                        抗生素治療失敗之原因

                                                                        選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                        • Slide 15
                                                                        • Slide 26
                                                                        • Slide 27
                                                                        • Slide 28

                                                                          Fluoroquinolones

                                                                          Group I

                                                                          - Nalidixic acid

                                                                          - Enteric or urinary tract infections Group II

                                                                          - Ciprofloxacin Ofloxacin Levofloxacin

                                                                          - GNR (P aeruginosa) S pneumoniae atypicals Group III

                                                                          - Moxifloxacin Gemifloxacin

                                                                          - GPB ( S pneumoniaeuarr) atypicals anaerobes GNR

                                                                          (P aeruginosadarr)

                                                                          - Respiratory tract infections

                                                                          GlycopeptidesGlycopeptides

                                                                          Vancomycin amp Teicoplanin

                                                                          Non-β-lactam cell wall synthesis inhibitor

                                                                          Spectrum GPC amp GPB

                                                                          Avoid oral use except AAC (antibiotic-associated colitis)

                                                                          Tetracyclines

                                                                          STD

                                                                          - Chlamydial

                                                                          diseases

                                                                          - Gonorrhea

                                                                          (doxycycline +

                                                                          ceftriaxone)

                                                                          - Syphilis

                                                                          Rickettsial diseases

                                                                          Brucellosis

                                                                          Tularemia

                                                                          Relapsing fever

                                                                          Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                          MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                          group Streptococcus pyogenes

                                                                          AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                          Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                          maltophilia

                                                                          Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                          Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                          aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                          E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                          colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                          day 60 kg man recommended dose for

                                                                          Colomycin is 240 to 480 mg of colistimethate sodium

                                                                          Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                          抗生素使用常見的五大錯誤

                                                                          Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                          bomb)

                                                                          Colonization

                                                                          Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                          Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                          抗生素使用的適應症

                                                                          明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                          常見感染症之抗生素療程 ( 一 )

                                                                          感染症療程 ( 天 )

                                                                          菌血症 敗血症 14

                                                                          肝膿瘍 21

                                                                          軟組織感染 7-10

                                                                          急性腎炎 14

                                                                          細菌性腦膜炎 10

                                                                          常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                          1048729

                                                                          肺炎雙球菌肺炎 14 ()

                                                                          革蘭氏陰性桿菌肺炎1048729

                                                                          21 ()

                                                                          退伍軍人協會症1048729

                                                                          21

                                                                          奴卡氏菌肺炎1048729

                                                                          180-360

                                                                          感染性心內膜炎 28-42

                                                                          抗生素治療失敗之原因

                                                                          選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                          • Slide 15
                                                                          • Slide 26
                                                                          • Slide 27
                                                                          • Slide 28

                                                                            GlycopeptidesGlycopeptides

                                                                            Vancomycin amp Teicoplanin

                                                                            Non-β-lactam cell wall synthesis inhibitor

                                                                            Spectrum GPC amp GPB

                                                                            Avoid oral use except AAC (antibiotic-associated colitis)

                                                                            Tetracyclines

                                                                            STD

                                                                            - Chlamydial

                                                                            diseases

                                                                            - Gonorrhea

                                                                            (doxycycline +

                                                                            ceftriaxone)

                                                                            - Syphilis

                                                                            Rickettsial diseases

                                                                            Brucellosis

                                                                            Tularemia

                                                                            Relapsing fever

                                                                            Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                            MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                            group Streptococcus pyogenes

                                                                            AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                            Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                            maltophilia

                                                                            Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                            Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                            aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                            E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                            colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                            day 60 kg man recommended dose for

                                                                            Colomycin is 240 to 480 mg of colistimethate sodium

                                                                            Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                            抗生素使用常見的五大錯誤

                                                                            Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                            bomb)

                                                                            Colonization

                                                                            Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                            Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                            抗生素使用的適應症

                                                                            明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                            常見感染症之抗生素療程 ( 一 )

                                                                            感染症療程 ( 天 )

                                                                            菌血症 敗血症 14

                                                                            肝膿瘍 21

                                                                            軟組織感染 7-10

                                                                            急性腎炎 14

                                                                            細菌性腦膜炎 10

                                                                            常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                            1048729

                                                                            肺炎雙球菌肺炎 14 ()

                                                                            革蘭氏陰性桿菌肺炎1048729

                                                                            21 ()

                                                                            退伍軍人協會症1048729

                                                                            21

                                                                            奴卡氏菌肺炎1048729

                                                                            180-360

                                                                            感染性心內膜炎 28-42

                                                                            抗生素治療失敗之原因

                                                                            選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                            • Slide 15
                                                                            • Slide 26
                                                                            • Slide 27
                                                                            • Slide 28

                                                                              Tetracyclines

                                                                              STD

                                                                              - Chlamydial

                                                                              diseases

                                                                              - Gonorrhea

                                                                              (doxycycline +

                                                                              ceftriaxone)

                                                                              - Syphilis

                                                                              Rickettsial diseases

                                                                              Brucellosis

                                                                              Tularemia

                                                                              Relapsing fever

                                                                              Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                              MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                              group Streptococcus pyogenes

                                                                              AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                              Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                              maltophilia

                                                                              Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                              Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                              aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                              E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                              colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                              day 60 kg man recommended dose for

                                                                              Colomycin is 240 to 480 mg of colistimethate sodium

                                                                              Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                              抗生素使用常見的五大錯誤

                                                                              Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                              bomb)

                                                                              Colonization

                                                                              Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                              Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                              抗生素使用的適應症

                                                                              明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                              常見感染症之抗生素療程 ( 一 )

                                                                              感染症療程 ( 天 )

                                                                              菌血症 敗血症 14

                                                                              肝膿瘍 21

                                                                              軟組織感染 7-10

                                                                              急性腎炎 14

                                                                              細菌性腦膜炎 10

                                                                              常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                              1048729

                                                                              肺炎雙球菌肺炎 14 ()

                                                                              革蘭氏陰性桿菌肺炎1048729

                                                                              21 ()

                                                                              退伍軍人協會症1048729

                                                                              21

                                                                              奴卡氏菌肺炎1048729

                                                                              180-360

                                                                              感染性心內膜炎 28-42

                                                                              抗生素治療失敗之原因

                                                                              選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                              • Slide 15
                                                                              • Slide 26
                                                                              • Slide 27
                                                                              • Slide 28

                                                                                Tigecycline (a new class Glycylcyclines)Gram-positive BacteriaGram-positive Bacteria Staphylococcus MRSA

                                                                                MRSE VRE E faecium E faecalis Streptococcus agalactiae S treptococcus anginosus

                                                                                group Streptococcus pyogenes

                                                                                AnaerobesAnaerobes B fragilis group Prevotella spp Peptostreptococcus spp C perfringensAtypicalAtypical Chlamydia pneumoniae Mycoplasma pneumoniae Legionella

                                                                                Gram-negative BacteriaGram-negative Bacteria E coli (including ESBLs) Kl ebsiella pneumoniae (including ESBLs) K oxytoca Acinetobacter baumannii (Resistant strains)Resistant strains) Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Stenotrophomonas

                                                                                maltophilia

                                                                                Does not have good activity Does not have good activity againstagainst P aeruginosa Proteus Providencia

                                                                                Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                                aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                                E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                                colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                                day 60 kg man recommended dose for

                                                                                Colomycin is 240 to 480 mg of colistimethate sodium

                                                                                Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                                抗生素使用常見的五大錯誤

                                                                                Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                                bomb)

                                                                                Colonization

                                                                                Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                                Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                                抗生素使用的適應症

                                                                                明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                                常見感染症之抗生素療程 ( 一 )

                                                                                感染症療程 ( 天 )

                                                                                菌血症 敗血症 14

                                                                                肝膿瘍 21

                                                                                軟組織感染 7-10

                                                                                急性腎炎 14

                                                                                細菌性腦膜炎 10

                                                                                常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                                1048729

                                                                                肺炎雙球菌肺炎 14 ()

                                                                                革蘭氏陰性桿菌肺炎1048729

                                                                                21 ()

                                                                                退伍軍人協會症1048729

                                                                                21

                                                                                奴卡氏菌肺炎1048729

                                                                                180-360

                                                                                感染性心內膜炎 28-42

                                                                                抗生素治療失敗之原因

                                                                                選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                • Slide 15
                                                                                • Slide 26
                                                                                • Slide 27
                                                                                • Slide 28

                                                                                  Colistimethate sodium Colistimethate sodium Pseudomonas

                                                                                  aeruginosa infections in cystic fibrosis multidrug-resistant Acinetobacter infection

                                                                                  E-coli Klebsiella sp ( ESBL) Enterobacter Colomycin 1000000 units = 80 mg

                                                                                  colistimethate 6 to 12 mgkg colistimethate sodium per

                                                                                  day 60 kg man recommended dose for

                                                                                  Colomycin is 240 to 480 mg of colistimethate sodium

                                                                                  Nephrotoxicity (damage to the kidneys) and neurotoxicity

                                                                                  抗生素使用常見的五大錯誤

                                                                                  Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                                  bomb)

                                                                                  Colonization

                                                                                  Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                                  Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                                  抗生素使用的適應症

                                                                                  明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                                  常見感染症之抗生素療程 ( 一 )

                                                                                  感染症療程 ( 天 )

                                                                                  菌血症 敗血症 14

                                                                                  肝膿瘍 21

                                                                                  軟組織感染 7-10

                                                                                  急性腎炎 14

                                                                                  細菌性腦膜炎 10

                                                                                  常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                                  1048729

                                                                                  肺炎雙球菌肺炎 14 ()

                                                                                  革蘭氏陰性桿菌肺炎1048729

                                                                                  21 ()

                                                                                  退伍軍人協會症1048729

                                                                                  21

                                                                                  奴卡氏菌肺炎1048729

                                                                                  180-360

                                                                                  感染性心內膜炎 28-42

                                                                                  抗生素治療失敗之原因

                                                                                  選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                  • Slide 15
                                                                                  • Slide 26
                                                                                  • Slide 27
                                                                                  • Slide 28

                                                                                    抗生素使用常見的五大錯誤

                                                                                    Antibiotic = scanol (antipyretic) S vs R (susceptible vs resistant) 4 gt 3 gt2 gt 1 Treat colonization Vancomycin+ imipenem(atomic

                                                                                    bomb)

                                                                                    Colonization

                                                                                    Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                                    Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                                    抗生素使用的適應症

                                                                                    明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                                    常見感染症之抗生素療程 ( 一 )

                                                                                    感染症療程 ( 天 )

                                                                                    菌血症 敗血症 14

                                                                                    肝膿瘍 21

                                                                                    軟組織感染 7-10

                                                                                    急性腎炎 14

                                                                                    細菌性腦膜炎 10

                                                                                    常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                                    1048729

                                                                                    肺炎雙球菌肺炎 14 ()

                                                                                    革蘭氏陰性桿菌肺炎1048729

                                                                                    21 ()

                                                                                    退伍軍人協會症1048729

                                                                                    21

                                                                                    奴卡氏菌肺炎1048729

                                                                                    180-360

                                                                                    感染性心內膜炎 28-42

                                                                                    抗生素治療失敗之原因

                                                                                    選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                    • Slide 15
                                                                                    • Slide 26
                                                                                    • Slide 27
                                                                                    • Slide 28

                                                                                      Colonization

                                                                                      Positive culture for sputum urine bile stool and skin swab without symptoms or signs of infection Not recommend for using antibiotics

                                                                                      Except asymptomatic bacteriuria before urological work up and in pregnancy should be treated

                                                                                      抗生素使用的適應症

                                                                                      明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                                      常見感染症之抗生素療程 ( 一 )

                                                                                      感染症療程 ( 天 )

                                                                                      菌血症 敗血症 14

                                                                                      肝膿瘍 21

                                                                                      軟組織感染 7-10

                                                                                      急性腎炎 14

                                                                                      細菌性腦膜炎 10

                                                                                      常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                                      1048729

                                                                                      肺炎雙球菌肺炎 14 ()

                                                                                      革蘭氏陰性桿菌肺炎1048729

                                                                                      21 ()

                                                                                      退伍軍人協會症1048729

                                                                                      21

                                                                                      奴卡氏菌肺炎1048729

                                                                                      180-360

                                                                                      感染性心內膜炎 28-42

                                                                                      抗生素治療失敗之原因

                                                                                      選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                      • Slide 15
                                                                                      • Slide 26
                                                                                      • Slide 27
                                                                                      • Slide 28

                                                                                        抗生素使用的適應症

                                                                                        明顯的細菌感染 極可能的細菌感染 敗血症 白血球過低合併發燒 懷疑急性心內膜炎 細菌性腦膜炎 壞死性筋膜炎

                                                                                        常見感染症之抗生素療程 ( 一 )

                                                                                        感染症療程 ( 天 )

                                                                                        菌血症 敗血症 14

                                                                                        肝膿瘍 21

                                                                                        軟組織感染 7-10

                                                                                        急性腎炎 14

                                                                                        細菌性腦膜炎 10

                                                                                        常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                                        1048729

                                                                                        肺炎雙球菌肺炎 14 ()

                                                                                        革蘭氏陰性桿菌肺炎1048729

                                                                                        21 ()

                                                                                        退伍軍人協會症1048729

                                                                                        21

                                                                                        奴卡氏菌肺炎1048729

                                                                                        180-360

                                                                                        感染性心內膜炎 28-42

                                                                                        抗生素治療失敗之原因

                                                                                        選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                        • Slide 15
                                                                                        • Slide 26
                                                                                        • Slide 27
                                                                                        • Slide 28

                                                                                          常見感染症之抗生素療程 ( 一 )

                                                                                          感染症療程 ( 天 )

                                                                                          菌血症 敗血症 14

                                                                                          肝膿瘍 21

                                                                                          軟組織感染 7-10

                                                                                          急性腎炎 14

                                                                                          細菌性腦膜炎 10

                                                                                          常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                                          1048729

                                                                                          肺炎雙球菌肺炎 14 ()

                                                                                          革蘭氏陰性桿菌肺炎1048729

                                                                                          21 ()

                                                                                          退伍軍人協會症1048729

                                                                                          21

                                                                                          奴卡氏菌肺炎1048729

                                                                                          180-360

                                                                                          感染性心內膜炎 28-42

                                                                                          抗生素治療失敗之原因

                                                                                          選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                          • Slide 15
                                                                                          • Slide 26
                                                                                          • Slide 27
                                                                                          • Slide 28

                                                                                            常見感染症之抗生素療程 ( 二 )感染症療程 ( 天 )

                                                                                            1048729

                                                                                            肺炎雙球菌肺炎 14 ()

                                                                                            革蘭氏陰性桿菌肺炎1048729

                                                                                            21 ()

                                                                                            退伍軍人協會症1048729

                                                                                            21

                                                                                            奴卡氏菌肺炎1048729

                                                                                            180-360

                                                                                            感染性心內膜炎 28-42

                                                                                            抗生素治療失敗之原因

                                                                                            選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                            • Slide 15
                                                                                            • Slide 26
                                                                                            • Slide 27
                                                                                            • Slide 28

                                                                                              抗生素治療失敗之原因

                                                                                              選用藥物不恰當 藥物交互作用 降低療效 異異物阻塞或膿瘍未引流 病人免疫力太差 分離菌之判讀錯誤 新的院內感染

                                                                                              • Slide 15
                                                                                              • Slide 26
                                                                                              • Slide 27
                                                                                              • Slide 28
                                                                                                • Slide 15
                                                                                                • Slide 26
                                                                                                • Slide 27
                                                                                                • Slide 28

                                                                                                  top related